POU domain genes and the immunoglobulin octamer motif in chickens by Heltemes, Lynn Marie
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
1997
POU domain genes and the immunoglobulin
octamer motif in chickens
Lynn Marie Heltemes
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
Part of the Immunology and Infectious Disease Commons, Medical Immunology Commons,
Molecular Biology Commons, and the Zoology Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Heltemes, Lynn Marie, "POU domain genes and the immunoglobulin octamer motif in chickens " (1997). Retrospective Theses and
Dissertations. 11463.
https://lib.dr.iastate.edu/rtd/11463
INFORMATION TO USERS 
This manuscript has been reproduced from the microfilm master. UMI 
films the text directly fi'om the original or copy submitted. Thus, some 
thesis and dissertation copies are in typewriter &ce, while others may be 
fi'om any type of computer printer. 
The quality of this reproduction is dependent upon the quality of the 
copy submitted. Broken or indistinct print, colored or poor quality 
illustrations and photographs, print bleedthrough, substandard margins, 
and improper alignment can adversely affect reproduction. 
In the unlikely event that the author did not send UMI a complete 
manuscript and there are missing pages, these will be noted. Also, if 
unauthorized copyright material had to be removed, a note will indicate 
the deletion. 
Oversize materials (e.g., maps, drawings, charts) are reproduced by 
seaioning the original, beginning at the upper left-hand comer and 
continuing fi'om left to right in equal sections with small overiaps. Each 
original is also photographed in one exposure and is included in reduced 
form at the back of the book. 
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6" x 9" black and white 
photographic prints are available for any photographs or illustrations 
appearing in this copy for an additional charge. Contact UMI directly to 
order. 
UMI 
A Bell & Howell Information Company 
300 North Zedj Road, Ann Arbor MI 48106-1346 USA 
313/761-4700 800/521-0600 

POU domain genes and the immunoglobulin octamer motif in chickens 
by 
Lynn Marie Heltemes 
A dissertation submitted to the graduate faculty 
In partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
Major: Immunobiology 
Major Professors: Susan J. Lamont and Christopher K. Tuggle 
Iowa State University 
Ames, Iowa 
1997 
UMI Number: 9725414 
UMI Microform 9725414 
Copyright 1997, by UMI Company. All rights reserved. 
This microform edition is protected against unauthorized 
copying under Title 17, United States Code. 
UMI 
300 North Zeeb Road 
Ann Arbor, MI 48103 
ii 
Graduate College 
Iowa State University 
This is to certify the Doctoral dissertation of 
Lynn Marie Heltemes 
has met the dissertation requirements of Iowa State University 
Co-major (^ofessor 
Co-major Professor 
For the Major Program 
uate College 
Signature was redacted for privacy.
Signature was redacted for privacy.
Signature was redacted for privacy.
Signature was redacted for privacy.
iii 
TABLE OF CONTENTS 
vi 
ix 
X 
1 
Introduction 1 
Dissertation Organization 2 
Literature Review 4 
References 32 
CHAPTER 2. TAQ\ POLYMORPHISM IN OCT-1 IN THE CHICKEN 47 
Probe Description/Source 47 
Polymorphism 47 
Hybridization Conditions 47 
Mendelian Inheritance 48 
Chromosomal Location 48 
Acknowledgments 48 
References 48 
CHAPTER 3. ISOLATION AND MAPPING OF TWO CHICKEN POU 50 
FAMILY GENES AND THE IDENTIFICATION OF A SYNTENIC GROUP 
WITH HUMAN AND MOUSE 
Summary 50 
Introduction 50 
Materials and methods 51 
Results 53 
LIST OF FIGURES 
LIST OF TABLES 
ABSTRACT 
CHAPTER 1. GENERAL INTRODUCTION 
iv 
Discussion 55 
Acknowledgments 57 
References 58 
CHAPTER 4. TISSUE EXPRESSION PATTERNS OF CHICKEN 63 
OCTAMER-BINDING PROTEINS 
Abstract 63 
Introduction 63 
Materials and Methods 64 
Results 67 
Discussion 68 
Acknowledgments 70 
References 71 
CHAPTER 5. THE CHICKEN LAMBDA IMMUNOGLOBULIN LIGHT 84 
CHAIN PROMOTER AND THE OCTAMER MOTIF 
Abstract 84 
Introduction 84 
Materials and Methods 85 
Results 88 
Discussion 88 
Acknowledgments 91 
References 92 
CHAPTER 6. GENERAL CONCLUSIONS 99 
References 103 
APPENDIX A. SOUTHERN BLOT ANALYSIS OF PORCINE 104 
OCT-2 AND AVIAN OCT-1 
V 
APPENDIX B. ISOLATION OF DNA CLONES 108 
APPENDIX C. EXPRESSION OF OCTAMER-BINDING PROTEINS 126 
APPENDIX D. EXAMINATION OF THE LAMBDA IMMUNOGLOBULIN 137 
LIGHT CHAIN PROMOTER AND THE OCTAMER MOTIF 
ACKNOWLEDGEMENTS 147 
vi 
LIST OF FIGURES 
CHAPTER 1 
Figure 1. The germ-line structure of human light and heavy chain genes 5 
and the chicken light chain genes. 
Figure 2. Organization and assembly of murine heavy chain and light 8 
chain variable region genes. 
Figure 3. The genetic basis of antibody diversity of chickens 10 
Figure 4. Transcriptional regulation of an "idealized" eukaryotic gene and 12 
flanking regions, and the factors and events that may regulate its 
transcription by RNA polymerase II. 
Figures. Immunoglobulin promoter region. 16 
Figure 6. Structural features of the POU-specific domain. 22 
Figure?. Structural features of the POU-homeobox domain. 23 
Figure 8. An example of the POUg domain (Oct-1) and its interaction with 23 
the octamer sequence. 
Figure 9. The POU domain is a bipartite DNA-blnding domain. 25 
vii 
CHAPTER 2 
Figure 1. Example of Taq\ polymorphism in East Lansing reference 49 
population labeled with chicken Oct-1. 
CHAPTER 3 
Figure 1. Example of Sad polymorphism in East Lansing reference 51 
population labeled with Epoc-1/Skn-1/Oct-11. 
Figure 2. Example oi PvuW polymorphism in East Lansing reference 51 
population labeled with Bm-3a. 
Figure 3. Diagram of syntenic group for linkage group E49. 52 
CHAPTER 4 
Figure 1. Sequence of normal and mutated octamer oligonucleotides. 75 
Figure 2. Competitor assay for MSB1 and DT40. 77 
Figure 3. Schematic of tissue expression of chicken octamer-binding 79 
patterns, human HeLa extract and mouse day 15 embryo extract. 
Figure 4. EMSA results for multiple chicken tissues. 81 
Figure 5. Supershift EMSA results for HeLa, DT40 and MSB1 extracts. 83 
VIII 
CHAPTER 5 
Figure 1. The reporter constructs for the chicken immunoglobulin 96 
lambda light chain promoter 
Figure 2. Results of CAT assay using multiple immunoglobulin 98 
promoter construct. 
APPENDIX B 
Figure 1. GenBank entry for chicken Bm-3a cDNA clone. 124 
Figure 2. Amino acid alignment of chicken Bm-3a coding sequence 127 
with other Bm-3 clones. 
Figure 3. GenBank entry for chicken Skn-1/Epoc-1/Oct-11 genomic 128 
clone. 
Figure 4. Amino acid alignment of chicken Skn-1/Epoc-1/Oct-11 coding 132 
region with other POU class II genes. 
APPENDIX D 
Figure 1. Comparison of RSV, CMV and SV40 promoters in chicken 145 
ix 
LIST OF TABLES 
CHAPTER 1 
Table 1. Cloned POU domain genes. 19 
Table 2. Sequence homologies amongst POU family members. 20 
APPENDIX A. 
Table 1. Chicken matching bands between different probes. 100 
Table 2. Porcine matching bands between different probes. 101 
APPENDIX B. 
Table 1. Probes used for genomic library screening 123 
Table 2. Results of secondary screening 123 
Table 3. Results of Southem blot with lambda DNA 124 
APPENDIX D. 
Table 1. Initial CAT assay results 144 
Table 2. Repeat CAT assay using standardized protein concentration 144 
X 
ABSTRACT 
This research was undertaken to test the hypothesis that POU genes exist in 
the chicken and are involved in transcriptional regulation. Transcriptional regulation 
of immunoglobulin genes provides a model for tissue-specific gene expression in the 
immune system. The POU protein Oct-2 has been hypothesized to partially regulate 
immunoglobulin gene expression through its interaction with the octamer motif found 
in the promoter of immunoglobulin genes. In searching for a chicken Oct-2 
homologue, two partial chicken POU domain genes were identified. A cDNA clone 
encoding the POU domain of Bm-3a was Isolated and showed near identity to the 
human Bm-3a sequence (100% at the a.a. level). Chicken Bm-3a was mapped to 
linkage group E48 in the East Lansing chicken genome mapping reference 
population. A Skn-1/Epoc-1/Oct-11 genomic clone was identified and mapped to 
chicken linkage group E49, to an area of synteny with human chromosome 11q23 
and mouse chromosome 9. Examination of octamer-binding protein expression 
patterns in multiple chicken tissues found that octamer-binding protein complexes 
existed in ovary, cerebrum, liver, lung, kidney, spleen, thymus, bursa, MSB1 (T cell 
line), and DT40 (B cell line). Every tissue had at least two octamer-binding proteins 
with a total of seven unique chicken protein complexes. A comparison between 
mouse and chicken octamer-binding proteins identified an unique chicken octamer-
binding protein, slightly faster migrating than mouse Oct-2. Chicken Oct-1 is 
expressed in all tissues except liver. The chicken immunoglobulin lambda light 
xi 
chain promoter contains an octamer motif (-106) and a TATA box (-70). Chicken B 
and T lymphocyte cell lines were used to detennine activity of both the promoter and 
the octamer motif. The promoter was functional only in the B cell line and required 
an enhancer sequence. Mutation of the octamer motif abolished the transcriptional 
activity of the immunoglobulin promoter. These results suggest that the chicken 
immunoglobulin promoter functions similariy to Its mammalian counter parts, in that 
the chicken immunoglobulin lambda light chain promoter plays a role in tissue-
specificity and requires an enhancer and an intact octamer motif. 
1 
CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
The immune system defends the body from attacks by cells or organisms 
considered to be "nonself." These include such things as cancerous cells, 
microorganisms, and parasites. Adaptive immunity is confen^ed through two 
different responses initiated by detection of a foreign antigen: humoral and cell-
mediated immunity. Cell-mediated immunity functions by the direct involvement of T 
lymphocytes, while humoral immunity utilizes circulating immune products, called 
immunoglobulins or antibodies, produced by B lymphocytes. Combining these two 
responses allows the immune system to effectively confer protection to an 
individual. 
Humoral immunity depends on B lymphocytes, which produce circulating 
immunoglobulins. Stimulation of B cells occurs through interaction between antigen 
and immunoglobulin molecules, which serve as cell surface receptors. Following 
antigenic stimulation, the B cells begin to transcribe the immunoglobulin genes. 
Regulatory elements of the immune system have not yet been fully described in 
either the human or the avian immune systems. The chicken provides a unique 
opportunity to examine immune function because of a specialized B cell 
compartment called the bursa of Fabricius. Modulation of the immune response 
could be helpful in the control of disease and dysfunctions of the immune system. 
Furthermore, it would lead to the possibilities of immunostimulation and 
immunosuppression. Further understanding of immunoregulation could also lead to 
improvements in animal health. 
An octamer motif (ATTTGCAT) can be found in both the immunoglobulin 
promoter and enhancer regions. The motif is important in both the rearrangement 
and the transcriptional regulation of immunoglobulin genes (Parslow, etai, 1984; 
Falkner and Zachau, 1984; Bergman ef a/., 1984; Queen and Stafford, 1984). 
Many octamer-binding proteins have been identified in mammals and the proteins 
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belong to the POU gene family. The two octamer-blnding proteins most likely to 
bind the immunoglobulin octamer motifs, Oct-1 and Oct-2, have been the center of 
much research. Oct-2, primarily expressed in B lymphocytes, is the most likely 
octamer-binding protein involved in immunoglobulin gene rearangement, though 
additional protein factors are needed to effect transcription and rearrangement. 
Therefore, a better understanding of the role of Oct-2 and the octamer motif in 
immune function could provide a possible means for regulating immunoglobulin 
production. Furthemore, Oct-2 provides a model for studying regulation of gene 
expression. 
Initial evidence indicated that POU proteins are conserved throughout evolution. 
This suggests that members of this family play a significant biological role, most 
likely in transcriptional regulation. Therefore, POU proteins provide a good model to 
study both transcription factors and transcriptional regulation. The POU proteins are 
involved in both tissue-specific and ubiquitous transcriptional regulation. 
As in humans, a chicken genome mapping project has begun. Insight into 
genome organization, a framework for identification and location of major genes 
influencing biological traits and chromosomal location of cloned genes are among 
the benefits of creating a molecular genetic map. In the chicken, two intemational 
reference populations have been created for public use in mapping. These maps 
are currently being used in mapping efforts in the chicken. 
The objective of this research was to detennine if POU additional POU genes 
exist in the chicken and are involved in transcriptional regulation. The 
immunoglobulin gene was used as a model to test this hypothesis by examining 
promoter activity of the immunoglobulin lambda light chain gene and by searching 
for POU genes known to play a role in the regulation of this promoter. Though 
some work has been done examining the controlling mechanisms of gene 
recombination, little research has been conducted on the transcriptional regulation 
of immunoglobulin gene expression in the chicken. 
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Dissertation Organization 
This dissertation Is written in the alternative fonnat. It begins with a literature 
review and is followed by four manuscripts, a general conclusion and two 
appendices. The first manuscript, "Taql polymorphism in Oct-1 in the chicken," was 
published in Animal Genetics. The second manuscript is entitled "Isolation and 
mapping of two chicken POU family genes and the identification of a syntenic group 
with human and mouse" and has been submitted to Animal Genetics. The third 
paper has been submitted to The Proceedings of the National Academy of 
Sciences, USA and Is titled "Expression pattems of octamer-binding proteins in 
several chicken tissues." The final paper, "Characterization of the lambda light 
chain immunoglobulin promoter and the role of the octamer motif, has been 
submitted to Immunogenetics. Following the manuscripts is a general conclusions 
section. References for the literature review are found following the literature review 
and each of the manuscripts includes the references used in the manuscript. 
Finally, four appendices were included providing additional research information with 
relevance to the general conclusions and detailed methodology used to perform the 
described research. 
Lynn Heltemes was the principle investigator on the research reported in each 
of the manuscripts and was the first author of the manuscripts; and was advised by 
co-major professors Susan Lamont and Christopher Tuggle. 
Literature Review 
Immunology Introduction 
The immune system consists of two main responses, humoral and cell-
mediated. Regulation of the immune system to differentiate self from non-self is 
dependent on molecules encoded by the major histocompatability complex (MHC). 
Humoral immunity depends on B lymphocytes, which produce circulating proteins 
called immunoglobulins. Stimulation of B cells occurs through an interaction 
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between antigen and immunoglobulin molecules which serve as cell surface 
receptors. After stimulation, the B cell transcribes the immunoglobulin genes. 
Immunoglobulins are responsible for antigen recognition and are the main 
component of the humoral immune response. Most immunoglobulin molecules are 
composed of two identical heterodimers linked by a disulfide bond. Each of the 
heterodimers is composed of one light chain and one heavy chain and each chain 
can be divided into a N-terminal variable (V) region and a C-terminai constant (C) 
region (Hilschmann and Craig, 1965; Titani etal., 1965). Constant domains mediate 
various effector responses, and the variable regions of the heavy and light chains 
form the antigen binding site. In mammals, there are two types of light chains (K -
kappa and k - lambda) and five types of heavy chains leading to five classes of 
immunoglobulins, IgG, IgM, IgA, IgE and IgD. Of these, four have been identified in 
the chicken, IgG, IgM, IgA, IgD (Leslie and Clem, 1969; Leslie and Clem, 1970; 
Lebacq-Vemneyden, Vaerman and Heremans, 1972; Orlans and Rose. 1972; 
Watanabe, Kobayashiand Isayama, 1975; Foppoli ef a/., 1979; Chen, Lehmeyer 
and Cooper, 1982). 
Immunoglobulin Gene Structure 
Immunoglobulin heavy chain variable regions are encoded by three separate 
gemi-line DNA elements, the Vh gene segment, the D (diversity) segment and the Jh 
O'oining) segment (Brack etal., 1978; Max, Seidman and Leder, 1979; Sakano et 
at, 1979; Early et al., 1980). The variable region of the light chains is composed of 
a V segment and a J segment. The gemi-line DNA elements are encoded in 
separate clusters in the mammalian genome. Somatic recombination events 
produce VhDJh (or VlUJ variable regions. 
The immunoglobulin germ-line gene structure differs between chickens and 
mammals (Figure 1). The most notable difference is the number of variable and 
joining segments, with only one variable and one joining segment in the chicken 
heavy or light chain genes (Reynaud et al., 1985; Reynaud, Dahan and Weill, 1983) 
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Human X Light Chain 
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V Vx Jx Ox 
Chicicen X Light Chain 
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M/V;^-25 Vx Jx Cx 
Human K Light Chain 
Vk - -80 Jk 
Human Heavy Chain 
Vh--100-300 DH-5 Jh • 9 Cp C5 Cy Cg C(X 
Figure 1 - The germ-line structure of human light and heavy chain genes and 
the chicken light chain genes. (V- variable gene segment(s), J - joining gene 
segment(s), D - diversity gene segment(s), C - constant gene segment(s) and 
i|/- pseudogene segment; Reynaud, Dahan and Weill, 1983; Staudtand 
Lenardo, 1991) 
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as compared to multiple V and J segments in the mouse light chain and heavy chain 
gemri-line (Tonegawa, 1983). 
In 1983, Reynaud, Dahan and Weill published the full sequence of the chicken 
lambda light chain. Previously, partial sequences had been identified and it was 
shown that the lambda light chain comprised 95% of the total chicken light chains 
(Grant, Sanders & Hood, 1971; Kubo, Rosenblum and Benedict, 1970). Mice and 
rats have 95% kappa chains; whereas. In humans, 70% of Immunoglobulins have 
kappa chains (Tizard, 1992). Interestingly, the variable region comparison of the 
lambda light chain DNA sequence between chicken and human showed higher 
homology (53-63%) than the comparison of mouse to human (31-42%, Reynaud, 
Dahan and Weill, 1983). The chicken to mouse variable region homology is lower, 
at only 42%. 
The genomic structure of the chicken light chain immunoglobulin gene contains 
a single V gene segment separated from a single functional joining gene segment 
by 1.8 Kb (Reynaud et ai, 1987). A single constant region is located two Kb 
downstream (3') from the joining segment. The leader segment is separated from 
the functional V element by an 125-bp intron and is 5' from a typical immunoglobulin 
promoter. Within 22 Kb upstream of the variable gene segment, 25 variable 
pseudogenes were identified. The pseudogenes lack leader sequences, as well as 
recombination signal sequences and are found in both orientations. 
The chicken heavy chain immunoglobulin gene structure also has single V- and 
J-encoding segments, but the D segment, found only in heavy chain genes, exists 
as a multigene cluster (Reynaud etai, 1989; Reynaud, Anquez and Weill, 1991). 
The Vh gene (VhI) is located 15 Kb upstream of the Jh segment with approximately 
15 D elements located between V and J (Reynaud ef a/., 1989). Starting 7 Kb 
upstream from Vh1 , is a cluster of pseudogenes (at least 45) spanning 60 to 80 Kb. 
Sixteen D segments were identified, with fifteen being extremely homologous to one 
another (Reynaud, Anquez and Weill, 1991). 
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Generation of Immunoglobulin Diversity 
Generation of immunoglobulin diversity is cmcial in protecting the individual from 
invasion by foreign antigens. The body would be unable to adequately defend 
against attacks from the outside environment without a large repertoire of 
antibodies, because it would be unable to recognize all of the foreign antigens 
bombarding the body. The large repertoire of antibodies is created through 
diversification in immunoglobulin genes. Human immunoglobulin diversity is 
generated through multiple germ-line V genes, VJ and VDJ somatic recombination, 
recombinational inaccuracies, light and heavy chain recombination, N-region 
additions and somatic mutation (Tonegawa etal., 1974; Tonegawa, 1983; Roitt, 
Brostoff and Male, 1993). 
The process of V(D)J recombination is a complex process that involves 
numerous components. It is an important process, as Is shown in a disease 
associated with a defect in V(D)J recombination, severe combined immune 
deficiency (SCID - Schuler et al., 1986). Conserved sequence motifs flank one or 
both sides of all gene segments known to rearrange. The consensus recombination 
signal sequence (RSS) consists of a dyad-symmetric heptamer sequence directly 
adjacent to the coding element and an A/T rich nonamer separated from the 
heptamer by a spacer region (12 or 23 bp) of nonconserved nucleotides (Early ef 
a/., 1980; Max, Seidman and Leder, 1979; Sakano etal., 1979). 
Immunoglobulin gene rean-angement occurs in an ordered fashion in humans. 
The first gene rean-angement is heavy chain D- to Jh rearrangement and occurs on 
at least one heavy chain allele and often on both (Figure 2; Alt et al., 1984). This 
rearrangement is required for further diversification (Alt et al., 1984; Schlissel 
Corcoran and Baltimore, 1991) and is not limited to 8 cells, as it has also been 
shown in T cells (Forster et al., 1980; Kurosawa et al., 1981). Next, precursor B 
cells undergo Vh to DJh rearrangement. Both rearrangements, D- to and Vh to 
DJh, occur by the process of intrachromosomal deletion (Alt et al., 1984). The next 
major stage of differentiation 
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Variable Region Gene Assembly: u o 
3 "1 '2b "23 
Vh Segments O Segments Segments (200-2000] (12) (4) 
V, V, V, 0, 0, 0,, J, J, J, J. 
D-to-J ^ Recognition ano cuRing 
Normal ' ' scid 
V, V, V, 0, 0, J, J, J. 
V, V, V. 0, J. V, V, V„ 0, D, J. 
V-to-DJ \ / Recognition and cutting "X / V-to-"DJ" 
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1.ICGenes: fl ffl H o-(~>.3-
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2.x Genes: 
*>•1 "''•3 ^^3 JXi Cj., 
Figure 2. Organization and assembly of murine heavy chain and light chain 
variable region genes. Black triangles represent 23 bp spacer recognition 
sequences and 12 bp spacer are represented by open triangles. The sc/'d model 
shows what happens when the joining of coding sequences to each other in the 
context of V(D)J recombinase is aberrant (Blackwell and Alt, 1989) 
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is the subsequent rean^angennent and expression of light chain genes. Kappa chain 
genes are usually rean-anged before lambda genes suggesting a hierarchy of light-
chain gene rearrangement (Alt ef a/., 1984; Hieterefa/., 1981; Coleclough a/., 
1981). 
Generally, the DNA splicing reactions only take place in one of the alleles for 
each chain. This phenomenon is known as allelic exclusion. Therefore, only one 
allele is expressed in each cell. It is believed that allelic exclusion is mainly due to 
recombinational en'ors (Coleclough et al., 1981). Originally, it was thought that this 
phenomenon existed in both the heavy and light chain genes, but in some 
instances, both kappa and lambda light chains are expressed in a cell (Alt et ai, 
1980). It is clear though, that cells only produce one functional light chain type. 
The chicken creates immunoglobulin diversity in a way different from mammals. 
Chickens rely on intrachromosomal gene conversion (Figure 3; Reynaud et al., 
1987,1989; Thompson and Nieman, 1987). Upstream from the single variable 
gene in the lambda light chain are 25 pseudo-variable genes (Reynaud etai, 1987) 
and approximately 45 pseudo-variable/diversity genes in the heavy chain (Reynaud 
efa/., 1989). They are classified as pseudogenes because either the coding 
segment is deleted at either end or the proper signals for recombination are missing, 
or both. Diversity is achieved by intrachromosomal gene conversion using 
sequence from the pseudo-V gene segments and Inserting it into the functional 
variable gene and in the D gene segment in the heavy chain. This process occurs 
four to ten times during B cell development (progressive sequence diversification), 
theoretically creating at least 10^^ distinct immunoglobulin molecules (Reynaud et 
ai, 1987,1989; Thompson, 1992). Immunoglobulin gene rearrangement is not an 
ongoing process in the chicken. Rearrangement of immunoglobulin genes only 
takes place in a single wave during embryogenesis. Therefore, the B-cell antibody 
repertoire is limited to the number of B cell precursors colonizing the bursa (2-3 x 
10" cells - Weill et al., 1986). Only one allele is productively rearranged in most 
mature B cells, while the other allele remains in the genn-line configuration 
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germ-line DNA 
pseudogenes 
rearrangement 
gene conversion 
B cell DNA 
Figure 3. The genetic basis of antibody diversity in chickens. The germ-line 
structure through gene conversion of the chicken immunoglobulin light chain (Roitt, 
Brostoffand Male, 1993). 
(Reynaud et ai, 1985,1989). In some instances (~8%) a complete germ-line 
configuration was Identified (Reynaud etal., 1989). 
Recent evidence suggests that there is ongoing gene conversion in the chicken 
(Arakawa ef a/., 1996). Arakawa and coworkers demonstrated post-bursal 
diversification of immunoglobulin genes in activated B cells located in splenic 
gemninal centers. This diversification is a result of both templated gene conversion 
and non-templated point mutations. 
Chicken immunoglobulin gene rearrangement takes place during days 10 and 
15 of embryogenesis in the splenic aniage and is completed by day 18 (Reynaud et 
al., 1985,1989; Weill etal, 1986; McCormack etai, 1989; Mansikka etai, 1990). 
Cells in which recombination is completed also have acquired the ability to migrate 
to the bursa of Fabricius, a developmental lymphoid organ. B cells expand from 3-5 
xlO" Ig-positive progenitor cells to 1-2 x 10® mature B cells In the bursa of Fabricius 
with all cells encoding the same V, D and J gene segments (Reyanud etai, 1987, 
1989; McCormack etal., 1989). Then progressive sequence diversification occurs 
by intrachromosomal gene conversion which Inserts pseudogene sequences Into 
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the associated variable gene segment (Reynaud etal., 1987,1989; Thompson and 
Nieman, 1987). This gene conversion process appears to be associated with 
transcription of the rearranged gene (Thompson, 1992). Rogozin and coworkers 
(1996) have recently suggested that there are two mechanisms in the chicken 
responsible for somatic hypermutagenesis, one mechanism beirig gene conversion 
and the other yet to be described. 
Four different elements have been identified as being important in the regulation 
of light chain chicken immunoglobulin gene rearrangement (Lauster et a!., 1993). 
There are two positive regulators, one negative regulator and one putative element 
believed to have a positive influence via its interaction with the negative regulator. 
The promoter and enhancer are the strong positive elements. The negative element 
is believed to be a strong transcriptional silencer that can be negated by an 
antagonizing effect by the putative element. Located between the and C;^. the 
silencer functions to control transcription from the genn-line sequence and is 
removed with recombination. Additionally, it seems that silencer activity is 
dependent on the octamer motif (Bulfone-Paus, Reiners-Schramm and Lauster, 
1995). 
Transcriptional Regulation 
Transcription is the process whereby an RNA message is created from DNA 
code. Therefore, transcription is an essential element in gene expression. 
Transcriptional regulation is a complex process with many factors and events 
influencing its outcome (Figure 4). Regulation of transcription is achieved by gene-
specific transcription factors (transcriptional activators) that bind regulatory elements 
in gene promoters and enhancers and stimulate the intrinsic, basal rate of 
transcription initiation (Cowell, 1994). 
A transcription factor, a trans-acting element, is defined as a protein that is 
required for the initiation of transcription, but is not part of the RNA polymerase 
complex (Lewin, 1994). The RNA polymerase II complex includes RNA polymerase 
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Figure 4. Transcriptional regulation of an "idealized" eukaryotic gene and flanking 
regions, and the factors and events that may regulate its transcription by RNA 
polymerase II. The differently patterned rectangles within the genetic segment 
symbolize response elements with different nucleotide sequences (Yanofeky, 1992). 
II, a complex often protein subunits, and a set of four proteins known as 
transcription factors IID, IIA, HE and IIB (Buratowski, etal., 1989; Reinberg and 
Roeder, 1987). Transcription factors are involved in the accurate initiation of 
transcription and in the control of tissue and/or cell-specific gene expression. 
Transcription factors may either directly bind a specific DNA sequence (DNA 
binding) or may interact with other transcription factors or proteins (protein-protein 
interactions - Nussinov, 1990). This transcriptional regulation either results in 
enhancement of transcriptional activation or in repression of transcriptional 
activation (Cowell, 1994; Latchman, 1995). The DNA region bound by transcription 
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factors is either the promoter or the enhancer region of the gene. 
Transcription factors are grouped into related families on the basis of sequence 
similarity in their proposed DNA-binding domains. Common DNA binding motifs 
include the Zinc finger, the basic region-leucine zipper, the p-sheet, the basic helix-
loop-helix and the helix-tum-helix (Pabo and Sauer, 1992; Yanbfsky, 1992). One 
hypothesis suggests that each family evolved from a common ancestral gene and 
evolution resulted in differences in the binding domain to allow for binding of unique 
sequences (Yanofeky, 1992). 
After DNA binding, the bound factor must affect the rate of transcription by 
either interacting directly with the RNA polymerase or with other transcription 
factors, or both. Transcription factor research has demonstrated the modular nature 
of transcriptional regulatory proteins, each with distinct regions being responsible for 
specific functions (Nussinov, 1990; Frankel and Kim, 1991). These regions may 
either be activation or repression domains. Multiple activation domains exist, 
including acidic domains, glutamine-rich domains and proline-rich domains. 
Transcriptional activators may also modulate chromatin structure or stimulate 
transcriptional elongation (Latchman, 1995). 
Along with transcriptional activators, there are molecules that are involved in 
repression of transcription (Cowel, 1994). The transcriptional repressor molecules 
fall into two broad classes, active (direct) and passive (indirect). As the name 
implies, active repressors function by directly inhibiting transcription. Passive 
repressors down-regulate transcription by interacting with one or more of the 
positively-acting transcription factors. One example of passive repression can be 
found in the proteins that bind GC-box, resulting in inhibition of the transcription 
factor Spl (Kageyama and Pastan, 1989). Other methods of repression include 
competition between two different activators for the DNA-binding site (Schule et ai, 
1990), formation of protein complexes with altered or impaired DNA-binding activity 
(Benezra etai, 1990) and by altering the transcriptional activating properties of 
transcriptional activators. Active transcriptional regulation appears, in part, to be 
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due to interactions with basal transcriptional machinery (Cowell, 1994). 
Expression of transcriptional factors may also be regulated. Two methods have 
been described thus far: controlling synthesis of the specific transcription factor 
(only made when necessary) or by regulating the activity of the transcription factor 
(Latchman, 1995). This activity regulation may include mechanisms such as post-
transcriptional modification (i.e. altemative splicing) or post-translational modification 
(i.e. phosphorylation - Lopez, 1995). 
Promoters and Enhancers 
C/s-acting elements that regulate and/or influence transcription are known as 
promoters and enhancers. A promoter is simply a region of DNA, located upstream 
from the transcription start site, that is involved in binding of the RNA polymerase to 
initiate transcription (Lewin, 1994). An enhancer is defined as a c/s-acting sequence 
that increases gene expression from some eukaryotic promoters (Lewin, 1994). 
Interesting and distinguishing features of an enhancer include its location (upstream, 
downstream or inside the gene) and its orientation (in either direction - Lewin, 1994). 
Unlike transcription factors, promoters and enhancers only affect the gene in which 
they are located (c/s-regulation). 
Both promoters and enhancers are composed of multiple genetic elements or 
modules (Sigler, 1988; Dynan, 1989). Each promoter contains at least one element 
responsible for positioning the RNA polymerase at the transcriptional start site. The 
best known example of this, found in the promoter region of many RNA polymerase 
II genes, is the TATA box. This sequence, TATAA, is usually located 25 to 30 bp 
upstream from the start site and, in many instances, is surrounded by a GC-rich 
region (McKnight and Kingsbury, 1982; Voet and Voet, 1995). Many additional 
modules can typically be found 30 to 110 bp upstream from the start site (Dynan, 
1989). Examples of additional modules are the GC (GGGCGG), the CAT box 
(CCAAT) and the octamer motif (ATTGCAT, Voet and Voet, 1995). 
As the name indicates, enhancers increase the activity of the promoter. An 
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enhancer, like a promoter, can also be involved in regulating tissue-specific 
expression (Lewin, 1994). The enhancing activity of regions/sequences outside of 
the promoter region was first identified for an SV-40 sequence (Banjeri, Rusconi and 
Schaffner, 1981; Moreau etal., 1981). p-globulin gene expression was enhanced 
200 times when a short (72 bp) SV40 DNA sequence was inserted into a reporter 
construct system (Banjeri, Rusconi and Schaffner, 1981). This activation was 
dependent on SV40 sequences acting In c/s; however, the activity was independent 
of orientation or exact location (distance from transcriptional initiation site). It 
appears that enhancer function involves some fonn 6f interaction with the basal 
transcriptional apparatus (RNA polymerase II and TATA binding factors), promoter 
or both. One possible mechanism for transcription factor regulation is that 
transcription factor may free DNA from nucleosomes, so as to make the genes more 
accessible to the transcription complex (Watson etal., 1992). Because enhancer 
regions are able to stimulate transcription from such a great distance (thousands of 
base pairs) it has been hypothesized that the intervening sequences, the region 
between the enhancer and RNA polymerase binding site, loops out allowing the 
enhancer and promoter regions to come into contact (Watson et al., 1992). 
Immunoglobulin Promoter 
The immunoglobulin promoter region plays an important role in transcriptional 
regulation and tissue specificity of immunoglobulin gene expression. 
Immunoglobulin genes are expressed specifically in B lymphocytes and plasma 
cells. Two sequence motifs important for regulation of immunoglobulin gene 
transcription have been identified in the promoter (Figure 5). The first of these 
sequences, the TATA motif, is common to many promoters whereas the other, the 
octanucleotide (octamer) motif, is found in fewer promoter regions. Immunoglobulin 
promoters are responsible for the lymphoid-restricted specificity and immunoglobulin 
expression. Deletion of the TATA-box and/or octamer motif from the immunoglobulin 
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Octamer TATA ATG V 
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Splice Site 
Figure 5. Human immunoglobulin promoter region (Parslow et al., 
1984). Octamer sequence: heavy chain ATGCAAAT, light chain 
ATTTGCAT. 
promoter drastically reduces transcription (Parslow et al., 1984; Falkner and 
Zachau, 1984; Bergman etai, 1984; Queen etaL, 1986; Queen and Stafford, 
1984; Grosschedl and Baltimore, 1985; Mason, Williams and Neuberger, 1985; 
Gopal etaL, 1985; Ballard and Bothwell, 1986). Researchers also demonstrated, 
using synthetic promoters with the TATA box and octamer motif, that these two 
elements are sufficient for lymphoid-restrlcted promoter activity (WIrth, Staudt and 
Baltimore, 1987; Drefuss, Doyen and Rougen, 1987). The TATA box is found 
approximately 30 bp upstream of the initiation site and the octamer motif Is found 70 
bp upstream from the initiation site (Figure 5). 
Additional immunoglobulin promoter sequence elements are involved in the 
transcriptional regulation of immunoglobulin genes. One conserved promoter 
element is the heptamer motif (CTCATGA, Eaton and Calame, 1987; Landolfi et al., 
1988). Mutation of the heptamer reduces promoter activity by 30-80%; but in the 
absence of the octamer, the heptamer has minimal. If any, activity (Poelllnger, Yoza 
and Roeder, 1989). Another conserved region In the promoter region Is a 
pyrimidine-rich sequence (Eaton and Calame, 1987). 
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Immunoglobulin Enhancer 
Additional important regulatory elements in immunoglobulin gene expression are 
the conserved enhancer regions. The enhancer sequences found in the 
immunoglobulin heavy chain gene (Banerji, Olson and Schaffriei', 1983; Gillies etal., 
1983; Neuberger, 1983) and kappa light chain (Bergman etal., 1984; Picard and 
Schaffher, 1984; Queen and Baltimore, 1983; Queen and Stafford, 1984) were the 
first identified eukaryotic enhancers (Lefranc and Lefranc, 1990). The 
immunoglobulin kappa gene has two enhancer sequences; the first is between the J 
joining segment and the C constant region (Picard and Schaffher, 1994; Queen and 
Stafford, 1984) and the second is located downstream of the C constant region 
(Meyer and Neuberger, 1989). One enhancer exists between the J joining segment 
and the switch sequence in the immunoglobulin heavy chain locus (Banjeri, Olson 
and Schaffner, 1983). Grosschedl and Baltimore (1985) demonstrated the 
requirement of the immunoglobulin heavy chain enhancer in immunoglobulin gene 
expression. Furthermore, they showed that the Immunoglobulin enhancer can be 
replaced by a viral enhancer without affecting gene expression. Multiple protein 
binding sites have been identified in the immunoglobulin gene using in vivo 
footprinting (Ephrussi etal., 1985). B-cell-specific binding was observed to the 
octamer, pEI, [iE2, piE3, |JE4 and possibly pB, Tl and pE5 motifs. Two enhancer 
elements (one proximal and one distal) have also been identified in the 
immunoglobulin lambda gene locus (Eccles etal., 1990). The proximal element is 
located 4 to 10 kb 3' of the gene and the distal element is located approximately 30 
kb 3' of the gene. 
A reoccuning promoter and enhancer sequence motif that can be found in many 
different gene regulatory regions is the octamer motif. It appears to be Important in 
many different systems and in many different cell types. There exists a family of 
proteins known to bind this region and they are called the octamer proteins. These 
proteins are encoded by a family of genes know as POU genes. 
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POU Family of Genes 
The POU proteins are a family of transcriptional and developmental regulatory 
proteins characterized by a conserved DNA binding domain called the POU domain. 
This domain was first identified by a comparison of three newly fdentified 
mammalian transcription factors and a developmental regulator from 
Caenorhabiditis elegans (C. elegans), a nematode (Herr et al., 1988). The acronym 
POU comes from the names of the originally identified protein sequences Pit-1, Oct-
1 & 2, and Unc-86 (Hen- etal., 1988). Pit-1 was isolated in rats (rat pituitary-specific 
transcription factor), Oct-1 and Oct-2 were first identified in humans (Clerc et al., 
1988; Ko etal., 1988; MilWeretal., 1988; Scheidereit etal., 1988; Sturm, Das and 
Herr, 1988) and Unc-86 was found in C. elegans (Chalfie, Horvitz and Sulston, 
1981). In recent years, many additional POU genes have been identified from many 
different species (Verrijzer and Van der Vliet, 1993; Wegner, Drolet and Rosenfeld, 
1993). 
The POU domain is 150 to 160 amino acids (a.a.) in length and is bipartite in 
nature (Wegner, Drolet and Rosenfeld, 1993). The first 75 to 82 a.a. of the 
complete POU domain belong to a subdomain called the POU-specific domain 
(POUs) which is then joined to a 60 amino acid POU homeodomain (POUHD) by a 
short variable linker region (Rosenfeld, 1991; Ruvkun and Finney, 1991). The POU 
domain has more recently been used as a tool for dividing the newly identified 
members of the family into classes. Originally, five classes of POU genes were 
identified by homology comparisons of the POU domain (Rosenfeld, 1991); more 
recently the genes have been divided into six classes (Venijzer and Van der Vliet, 
1993; Wegner, Drolet and Rosenfeld, 1993). Table 1 lists the POU classes and 
some of the POU genes, including the species from which they were isolated. 
There are a differing levels of homology among all four of the originally identified 
POU sequences (Table 2). The greatest similarity in the POU domain region is 
between Oct-1 and Oct-2, where there is an 87% similarity between amino acid 
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Table 1. Cloned POU domain genes (Venijzer and Van der Vliet, 
1993 and Wegner, Droletand Rosenfeld, 1993). 
Class Gene Organism 
1 Pit-1 / GHF1 Rat / human / mouse / pig / turkey / 
bovine 
II Oct-1 Human / chicken / rat / mouse / pig 
Oct-2 Human / mouse / rat / pig 
Oct-11 Mouse / pig^ 
Skn-li /Skn-1a / Rat / mouse 
Epoc-1 
dOct1 /dP0U19/ DrosophUa 
pdml 
dOct2/dPOU28/ Drosophila 
pdm2 
III Bm-1 Rat / mouse / pig^ 
Bm-2 Rat / mouse 
Bm-4 / RHS2 Rat / mouse 
SClP/0ct-6/Tst-1 Rat / mouse 
XLPOU-1 Xenopus 
IV unc86 C. elegans 
Bm-3 Rat / mouse / human / pig^ 
RDC-1 Human 
V Oct-3 / 4 Mouse / human 
Oct-25 Xenopus 
VI POU[C] Zebrafish 
^ POU domain region only 
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Table 2. Sequence homologies among POU family members^ 
POU Subdomains 
Sequence Comparison POU Domain Specific Homeobox 
159-170 75-83 60 
(%) (no.) (%) (no.) (%) 
Oct-1:0ct-2 87 (162) 99 (75) 88 
Oct-1 :Pit-1 52 (164) 61 (80) 57 
Oct-1 :unc-86 45 (166) 52 (82) 47 
Oct-2;Pit-1 50 (167) 61(80) 55 
Oct-2:unc-86 42 (169) 52 (82) 45 
Pit-1:unc-86 44 (159) 53 (83) 45 
POU Family 34(170) 43 (83) 37 
^The percentage of identical amino acids over the total number of 
residues for each region is shown for each pair-wise combination and for all four 
POU proteins together (Herr et ai, 1988). 
sequences between the two POU domains (Herr et aL, 1988). In the POUg region 
of Oct-1 and Oct-2, 74 of the 75 a.a. are identical, whereas in the POUHD region 53 
of 60 a.a. are identical (Clerc etal., 1988). The POUg domain is, therefore, more 
conserved than is the POUHD in this gene family (Herr et ai, 1988; Rosenfeld, 1991). 
There is approximately a 50% amino acid sequence similarity in the POU domain 
region among other members of the family (Herr et ai, 1988). The chicken Oct-1 
protein showed a 96% amino acid homology with the human Oct-1 sequence, much 
greater homology than is generally seen between human and chicken gene 
sequences (Petryniak et ai, 1990). This indicates extreme conservation of this 
sequence during evolution, suggesting that this protein performs an important, 
conserved function (Petryniak et ai, 1990). The conservation of sequence 
homology between different species has also been reported with other members of 
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the POU gene family (Lloyd and Sakonju, 1991; Wong, Silsby and El Halawani, 
1992; TuggleefaA, 1993; Tuggle, Helm and Rothschild, 1994). 
As previously mentioned, the POU domain is divided into two subdomains: 
POUs and POUHQ. The POUg domain is not only involved in, but a necessary 
component of, DNA binding. In fact, this domain is responsible for much of the 
binding site specificity and is required for high affinity and site-specific binding 
(Rosenfeld, 1991). Furthermore, recognition of specific binding sites of the 
homeodomain are modified by the POUg domain (Rosenfeld, 1991). The amino and 
carboxy terminal boundaries of the POUg domain contain clusters of acidic amino 
acids, whereas the boundaries of the two POUg subdomains are rich in basic amino 
acids (Ven'ijzer and Van der Vliet, 1993). Originally, the POUg domain was thought 
to consist of two highly conserved regions called A and B (Henr et ai, 1988). More 
recently, nuclear magnetic resonance (NMR) research by Assa-Munt and coworkers 
(1993) showed that the POUs domain is made up of four a helices. Figure 6 
illustrates features of the structure of the POUg domain. NMR studies of the Oct-1 
POUg domain have also shown the domain to display a structure similar to the tetra-
a-helical helix-tum-helix (HTH)-containing structure found in the DNA-binding 
domains of the lambda and 434 bacteriophage repressors and 434 Cro (Assa-Munt 
et a/., 1993; Dekker et al., 1993). 
The other subdomain, the POUHD, 'S related to the homeobox domain of genes 
known as homeobox genes, originally identified In Drosophila (Rosenfeld, 1991). 
Though the conservation of the homeobox domain is not strong between these two 
families of genes, there are some structural similarities. Both protein domains 
contain a helix-tum-hellx structure known to be important in DNA binding (Scott et 
al., 1989; Gehring etal., 1992; Rosenfeld, 1991). The helix-tum-helix motif of the 
POUHD consists of three helices. The first two are not well-conserved between POU 
family members but the third helix, also called the WFC region [in reference 
to tryptophan (W), phenylalanine (F) and cysteine(C) - Herr etal., 1988], is highly 
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Figure 6. Structural features of the POU-specific domain. Invariant residues in the 
POUs are listed. The lower boxes represent a-helical structures. Conserved 
clusters of acidic (-) and basic (+) residues are depicted (Verrijzer and Van der Vliet, 
1993). 
conserved (Rosenfeld, 1991). The third helix of this helix-turn- helix motif is critical 
to DNA binding: deletion or disruption of this helix completely abolishes binding 
(Rosenfeld, 1991). This helix is also refen-ed to as the recognition helix because it is 
predicted to directly contact the DNA (Wegner, Drolet, and Rosenfeld, 1993). Of the 
17 a.a. that make up the third helix, twelve are invariant, with residue nine, a 
cysteine residue, being identical In every family member identified so far (Verrijzer 
and Van der Vliet, 1993; Wegner, Drolet and Rosenfeld, 1993). All members of the 
POU-domain gene family have RVWFCN amino acid residues in their recognition 
helix (Rosenfeld, 1991). Important, also, to the DNA binding of this subdomain is 
the amino- and carboxy-temiinal boundaries which are made up of basic amino acid 
residues critical for their role as transcription factors (Rosenfeld, 1991). Figure 7 
shows a diagram of the general structure of the POUHD- Lastly, the POUHD has been 
shown to be highly conserved among POU-domain proteins (Rosenfeld, 1991). 
The POU domain plays an important role in the recognition of specific DNA 
sequences, which assists the POU proteins in their role as transcription factors. It is 
characterized by two structurally independent DNA-binding domains connected by a 
flexible linker (Klemm etal., 1994). The binding site for the POU-domain is an 
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Figure 7. Structural features of the POU-homeobox domain. Invariant residues in 
the POUHD are listed. The boxes represent a-helical structures. Conserved clusters 
of basic (+) residues are depicted (Verrijzer and Van der Vliet, 1993) 
B Model 
Figure 8. A schematic example of the POUs domain (Oct-1) and its interaction with 
the octamer sequence. The shaded a-helices represent the putative helix-tum-helix 
element. Figure B illustrates the interaction of the POUs domain with the 5' 
sequence of the octamer motif (Jansco et al., 1994). 
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asymmetric element spanning 12 to 15 base pairs (Rosenfeld, 1991). The proteins 
have also been shown to bind flanking sequence, allowing some degeneracy in the 
DNA binding motif (Figure 8 - Wegner, Drolet, and Rosenfeld, 1993). The POUs 
domain contacts the ATGC (5') sequence and the POUHD domain contacts an AAAT 
(3') sequence (Klemm et a!., 1994). The two domains bind the DNA opposite each 
other In the major grooves of the DNA molecule (Verrijzer and Van der Vliet, 1993; 
Klemm etal., 1994). Figure 9 illustrates the proposed POU domain DNA-protein 
interaction. Oct-1 and Oct-2 recognize a specific octamer sequence (ATTTGCAT) 
(Petryniak et al., 1990; Elsholtz et a!., 1990). Absence or slight changes in this 
sequence leads to the loss of transcriptional regulation, but not necessarily to the 
loss of recognition (Elsholtz etal., 1990). Many other members of the POU domain 
family also appear to bind AfT rich regions (Clerc et al., 1988). The importance of 
this binding is not yet fully understood. 
Oct-1 
Oct-1, the largest of the known octamer-binding proteins, was first identified in 
humans and has now been identified in many species including mouse, Xenopus 
and chicken. Oct-1, also known as NFIII, OTF-1, OBP100 or NF-A1, is ubiquitously 
expressed and has an approximate molecular weight of 97 Kd (Pierani etal., 1990). 
It is classified as a Class II POU gene (Rosenfeld, 1991). The human gene is 
encoded by sixteen exons which span over 150 kb of the genome (Sturm et al., 
1993). Four of the sixteen exons make up the POU domain portion of the protein 
(Sturm etal., 1993). The reading frame of Oct-1 is 766 a.a. in length. In both 
mouse and humans, the Oct-1 gene maps to chromosome 1. In the mouse, there 
are multiple fonns of the Oct-1 protein which are believed to be a result of post-
transcriptional modification(s) (Suzuki et al., 1993). It seems that Oct-1 is not 
involved in autoregulating transcriptional activation, which is suggested by the 
observation that Oct-1 mRNA is not coupled to DNA replication (Sturm et a/., 1993). 
Because there is little change in the Oct-1 protein level during the cell cycle, post-
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POU ajTATGC^AAT^t 
POL's gAATAT^CA 
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POU 
Figure 9. The POU domain is a bipartite DNA-binding domain. A. 
Alignment of the Oct-1 target sequences for the different regions of 
the POU domain interaction with the octamer motif. B. Approximated 
position of the POU domain interaction with the DNA (Verrijzer and Van 
derViiet, 1993). 
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transcriptional modifications such as phosphorylation are more likely to be involved 
in regulation of Oct-1 activity (Roberts, Segil and Heintz, 1991; Segil, Roberts and 
Heintz, 1991). A site in the Oct-1 homeobox domain is hyperphosphorylated as the 
cell enters mitosis and this phosphorylation is reversed as the cell leaves mitosis 
(Roberts, Segil and Heintz, 1991; Segil, Roberts and Heintz, 1991). Additionally, 
this phosphorylation inhibits protein-DNA interactions thereby providing a means of 
transcriptional regulation by controlling the activity of the transcription factor (Segil, 
Roberts and Heintz, 1991). 
Many ubiquitous and cell-specific promoters, as well as viral promoters, contain 
an octamer motif (ATGCAAAT) that mediates transcriptional regulation and DNA 
replication. Oct-1 has been shown to be active in binding both viral and cellular 
promoter octamer motifs. These include motife found in histone H2B genes, 
snRNA, adenoviral DNA (Verrijzer, Kal and Van der Vliet, 1990) and HSV immediate 
early genes (Katan et al., 1990). More recently, Oct-1 has been shown to be 
involved in the transcriptional activation of gonadotropln-releasing hormone by 
interacting with an A/T-rich enhancer region found in this gene (Clari< and Mellone, 
1995). This suggests that Oct-1 may play a role in tissue-specific transcriptional 
regulation and not just regulation of transcription of general housekeeping genes. 
Recent research suggests that Oct-1 may function by facilitating promoter 
recruitment of basal transcription complex factors (Mittal, et al. 1996; Nakshatri, 
Nakshatri and Currie, 1995). One of these recruited factors, TFIIB, a part of the 
preinitiation complex, seems to interact with Oct-1 (Nakshatri, Nakshatri and Cume, 
1995). Their research suggests that this interaction plays a role in positioning the 
site of transcription initiation. 
Oct-2 
Closely related to Oct-1, Oct-2 (also known as OTF-2 and NF-A2) is another 
member of the Class II POU gene family. It too binds the conserved octamer motif 
but is expressed in a restricted tissue pattern (Singh etal., 1986; Staudt etal., 
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1988). Originally, it was believed to be expressed only in B lymphocytes, but Oct-2 
has now been shown to also be expressed in kidney and brain (Scholer et al., 
1989). Oct-2 is encoded by a single gene in humans (Clerc etal., 1988; 
Scheidereit etal., 1988; Staudtef a/., 1988) but alternative-splicing results in 
multiple isoforms (Stoykova etal., 1992; Wirth etal., 1991). Tissue-specific 
regulation of the altemative splicing results in different forms of the proteins being 
produced in B cells and neuronal cells (Lillycrop and Latchman, 1992; Stoykova et 
al., 1992). Two forms of Oct-2, which differ in size and function, were identified in 
the mouse and named Oct-2a (60 Kd, 463 a.a.) and Oct-2b (75 Kd, 583 a.a.: 
Hatzopolous etal., 1990). In mouse, Oct-2 is located on chromosome 7 and in 
humans Oct-2 is on chromosome 19 (Clerc etal., 1988; Siracusa etal., 1991). 
The Oct-2 protein displays a complex, modular structure, containing separate 
activation and repression domains (Friedl and Matthias, 1996). The repression 
domain appears to be unique and displays cell type-specific characteristics. An 
early hypothesis that Oct-2 was responsible for the B-cell-specific function of 
immunoglobulin promoters was based on the finding that Oct-2 is primarily B-cell 
restricted (Staudtefa/., 1986; Landolfi, Capra and Tucker, 1986). This hypothesis 
was further supported by the observation that ectopic expression of Oct-2 in non-B 
cells stimulated transcription from artificial B-cell-specific promoters (Gerster, 
Blamaceda and Roeder, 1990; Tanaka and Herr, 1990; Miiller ef a/., 1988; Muller-
Immergluck et al., 1990). Several challenges to this hypothesis arose with 
subsequent research. In cotransfection assays with normal immunoglobulin 
promoters, ectopic Oct-2 expression was ineffective at activating transcription 
(Gerster, Blamaceda and Roeder, 1990). Oct-2 protein levels were not strictly 
correlated with the level of immunoglobulin expression (Cockerill and Klinken, 
1990; Hatzopolous ef a/., 1990; Pfisterer ef a/., 1994). Finally, Oct-1 was able to 
activate immunoglobulin promoters as efficiently as Oct-2 (Pierani etal., 1990; 
LeBowitz et al., 1988; Pfisterer et al., 1994). 
A search for a factor that interacted with Oct-2 in a tissue-specific manner 
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resulted in the identification of multiple proteins. These include: NTF (N element 
bound transcription factor: Yoza and Roeder, 1990), OCA-B (Oct coactivator from 
B cells: Luo etal., 1992), OBF-1 (Oct-binding factor-1: Strubin, Newell and 
Matthias, 1995) and Bob1 (B cell factor Gstaiger etal., 1995). Oct-2 null mutant 
mice showed that Oct-2 is required for maturation of immunoglobulin-secreting cells, 
but not for the generation of these cells (Corcoran etal., 1993). Additionally, the null 
mutant mice all died within hours of birth, indicating another essential, undetermined 
organismal function of Oct-2 (Corcoran et al., 1993). Radomska and coworkers 
(1995) suggested a role for Oct-2 in immunoglobulin gene silencing through an 
interaction with an additional B-cell factor. This was demonstrated by gene fusion in 
myeloma cells. Their work also demonstrated that the constitutive expression of 
human Oct-2 in mouse cells affected the mouse Oct-2 gene, suggesting a possible 
autoregulatory mechanism. 
Epoc-1/Skn-1/Oct-11 
Multiple Class II POU genes have been identified in addition to the original Oct-
1 and Ocf-2 genes, including Oct-11 {OBP-11), Epoc-1 and Skn-li/a (Yukawa etal., 
1993, Goldsborough et al., 1993 and Andersen et al., 1993). The three genes were 
independently identified but are apparently the same gene isolated in different 
species. Oct-11 appears to be a post-transcriptional modification of Epoc-1. These 
two proteins differ only at their 3' ends, with Epoc-1 being 28 a.a. longer. In the 
instance of Oct-2, there are differentially spliced products from the same transcript 
and this may also be true of Epoc-1 and Oct-11. 
Epoc-1 stands for epidermal octamer-binding factor. Epoc-1 is expressed in 
skin, thymus, stomach and testis of the mouse. In the thymus it Is found in thymic 
stromal cells and in the skin it is found in epidermal basal cells. Epoc-1 is 431 a.a. 
in length and is homologous to both Oct-1 and Oct-2. The POUg domain is almost 
identical to Oct-1 and Oct-2; in contrast, 13 out of 60 a.a. of the POUHoare different 
and the linker region shares no homology with any of the known POU proteins. 
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Initial studies with Epoc-1 have not shown the target of this presumed transcription 
factor (Yukawa et ai, 1993). 
Oct-11 binds the octanner sequence and is expressed during embryogenesis 
and in the adult thymus and testis. Two unlinked genes were identified in the 
mouse (Goldsborough etal., 1993). The first location is chromosome 1 but this 
transcript is likely to be a pseudogene. The second location is mouse chromosome 
9 (long arm of human chromosome 11 (q23), a region frequently translocated in 
acute lymphoblastic leukemias (Goldsborough etal., 1993). The POU domain 
genomic region of Oct-11 contains three introns located in the same places as in 
Oct-2. Two of these three introns are in similar positions in other POU genes 
including Pit-1 and unc-86. This conservation of intron junctions supports the 
possibility that there existed a common ancestor gene. Finally, the amino terminal is 
most closely related to Oct-2 and is a region involved in transcriptional activation, 
indicating a possible function for the Oct-11 gene. 
In the rat, Skn-la has a differentially spliced product known as Skn-li. The 
expression of the Skn-1 proteins Is localized to terminally differentiating epidermis 
and hair follicles. The difference between Skn-la and Skn-li is that there is a 113 
a.a. replacement of the initial 31 a.a. of the Skn-li protein in Skn-la. This amino 
terminal region in Skn-li has been shown to inhibit DNA binding and can also inhibit 
transactivation by Oct-1. The POU domain of skn-1 i/a, minus the linker region, 
differs from Oct-1 and Oct-2 by only 15 a.a., but the linker region is divergent fi"om 
the other POU genes. Cytokeratin 10 (K10) gene expression can be activated by 
Skn-la (Andersen etal., 1993). Neither of the Skn-1 proteins is able to activate or 
effectively bind the immunoglobulin octamer-heptamer site. These two proteins, 
Skn-la and Skn-li, provide a possible model for studying tissue-restricted activating 
and inhibitory functions by closely related transcriptional regulatory proteins 
(Andersen etal., 1993). 
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Bm-3 
POU domain genes from all classes are expressed in the mammalian brain. He 
and coworkers (1989) identified the Bm-3 family of proteins. Bm-3 are class IV POU 
genes. Three different Bm-3 genes have each been identified in mouse, rat and 
human (Bm-3a, also known as Bm 3.0 and RDC-1: Collum etal., 1992; Genrero et 
al., 1993; Lillycrop etal., 1992, Bm-3b, also known as Bm-3.2: Lillycrop etal., 
1992; Turner ef al., 1994, and Bm-3c, also known as Bm-3.1: Gerrero ef a/., 1993; 
Ninkina et al., 1993). All three of these factors are expressed in sensory neurons 
and exhibit distinct but related pattems of gene expression in the developing and 
adult nervous systems (Gen-ero etal., 1993; He etal., 1989; Lillycrop etal., 1992; 
Ninkina etal., 1993; Thiel etal., 1993; Tumer, Jenne and Rosenfeld, 1994; Xiang et 
al., 1993). Brn-3 factors are also expressed in neuroepitheliomas and Ewing's 
sarcomas (Collum etal., 1992) 
The POU domain and an additional amino terminal domain are well-conserved 
among Brn-3 genes but outside these domains there is little sequence homology 
(Thiel etal., 1993). The amino terminal domain is approximately 100 a.a. in length 
and is an activation domain (Thiel etal., 1993; Budhram-Mahadeo etal., 1996). 
Bm-3a and Bm-3c each contain an intron at approximately the same position, but 
Bm-3b contains no introns (Thiel etal., 1994). The three genes map to Independent 
locations in the mouse, with Bm-3a mapping to 14 E1-3, Bm-3b to X E1-5 and Bm-
3c to 18 B3-E1 (Thiel etal., 1994). Human Bm-3a (RDC-1) has been mapped to 
chromosome 13 (Collum etal., 1992). Two protein variants of Bm-3a have been 
identified and were called Bm-3(s) and Bm-3(l) (Thiel etal., 1993). Bm-3a(s) lacks 
84 a.a. from the conserved amino temninal domain (Thiel etal., 1993). 
The Bm-3 proteins have different functions. Bm-3a stimulates an artificial test 
promoter sequence containing the octamer motif (Monis et al., 1994), pro­
opiomelanocortin promoter (Tumer, Jenne and Rosenfeld, 1994) and the a-
intemexin promoter (Budhram-Mahadeo et al., 1995). In contrast, Bm-3b represses 
both the octamer test promoter (Budhram-Mahadeo etal., 1994) and the a-
31 
intemexin promoter (Budhram-Mahadeo ef al., 1995), as well as interfering with 
activation by Bm-3a (Budhram-Mahadeo etaL, 1994; Budhram-Mahadeo etal., 
1995; Morris etal., 1994). Both Bm-3a and Bm-3b bind single-stranded DNA, the 
first example of this type of binding with POU family proteins (Budhram-Mahadeo et 
al. 1996). Bm-3a(l) is able to tumorgenically transform fibroblasts but when Brn-3b 
is cotransfected with Bm-3(l), tumor transformation is abolished (Thiel etal., 1993). 
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CHAPTER 2. TAQ\ POLYMORPHISM IN OCT-I IN CHICKENS 
A molecular marker published in Animal Genetics 
L M Heltemes\ C K Tuggle^, S J Lamonf 
Probe description/source 
The probe was a 1283 bp EcoRI fragment (Clone 995) from chicken Oct-1 
cDNA (Petryniak et al. 1990). It contained the POD homeobox and 3' flanking 
sequence from the gene. The insert was excised from pGEM-Blue and isolated by 
electroelution. 
Polymorphisms 
The parents from the East Lansing chicken gene mapping reference population 
(Crittenden etal. 1993) were screened for restriction polymorphisms using 7 
enzymes {Psti, PvuW, Taq\, H/ndlll, EcoRI, Sad and BamHl). After identification of a 
Taql polymorphism, 44 progeny were genotyped. No polymorphisms were identified 
with the other 6 enzymes. 
Hybridization conditions 
The Oct-1 cDNA probe was labeled with pP]dCTP by the random priming 
technique. The Taql mapping blots (Spike etal. 1996) were hybridized ovemight at 
65° in 0.263 Na2HP04, 7.0% SDS, 1.0 mM EDTA and 1.0% BSA and washed four 
times to a final stringency of IX SSC, 0.1 % SDS for 20 minutes at 65°. 
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Mendelian inheritance 
Segregation of the Taq\ alleles consistent with Mendelian inheritance was 
observed for the 44 progeny in the four half-sib families of the reference population. 
Chromosomal location 
Unlinked in the East Lansing chicken mapping population. 
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Figure 1. Soutliern blot of Taq\ polymorphism in East Lansing reference 
population labeled with chicken Oct-1. 1, Jungle fowl x White Leghorn F1 sire; 
2, 17-18, White leghorn dams; 3-7, 9-16 progeny; 8, Lambda BSTBl marker. 
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CHAPTER 3. ISOLATION AND MAPPING OF TWO CHICKEN POU 
FAMILY GENES AND THE IDENTIFICATION OF A SYNTENIC 
GROUP WITH HUMAN AND MOUSE 
A paper submitted to Animal Genetics 
L M Heltemes\ C K Tuggle^, S J Lamonf 
Summary 
Two partial chicken POU domain genes were isolated by using POU domain 
homology as a tool in genomic library screening and RT-PCR. A cDNA clone 
encoding the POU domain of Bm-3a was isolated. The sequence showed near 
identity to human Bm-3a sequence and 100% conservation at the predicted protein 
level. Bm-3a was mapped to linkage group E48 in the East Lansing chicken 
genome mapping reference population. A Skn-1/Epoc-1/Oct-11 genomic clone was 
identified and the gene was mapped to linkage group E49 in the chicken. This 
mapping identified a syntenic group in linkage group E49 in the chicken conserved 
with human chromosome 11q23 and mouse chromosome 9. 
Introduction 
The POU genes are a family of transcriptional and developmental regulatory 
proteins characterized by a conserved DNA binding domain called the POU domain 
(Herr et al. 1988). The POU family of genes has been further subdivided into six 
classes based on homology in the consen/ed POU domain (Verrijzer and Van der 
Vliet 1993; Drolet and Rosenfeld 1993). The POU domain is characterized by two 
^Program of Immunobiology and ^Department of Animal Science, Iowa State 
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structurally independent DNA-binding domains connected by a flexible linker region 
(Klemm et al. 1994). These two well-conserved domains are called the POU-
specific (POUg) and the POU-homeobox (POUHQ) domains. 
POU domain genes have been identified in a variety of animals and display 
diverse protein expression pattems (Scholer et al. 1989; Verrijzer and Van der Vliet 
1993). Oct-1, a ubiquitously expressed POU octamer-binding protein, has been 
identified in the chicken (Petryniak etal. 1990). The identification of chicken Oct-1 
demonstrated the conservation of sequence (predicted protein sequence similiarity 
96%) for one member of the POU family of genes between mammals and chickens. 
Here, we describe the cloning, partial sequencing and mapping of two additional 
chicken POU genes. We show conservation of sequence and chromosomal 
location, including the identification of a syntenic group conserved amongst chicken, 
human and mouse. 
Materials and methods 
Genomic library screen 
A white Leghorn chicken genomic library (Clontech, Palo Alto, CA, USA) was 
screened with a cocktail of POU family gene probes, including two porcine Oct-2 
POU domain probes (one genomic and one cDNA; Tuggle etal. 1993; Tuggle etal. 
1994), 2 chicken Oct-1 probes (Petryniak etal. 1990), 1 rat Pit-1 POU domain probe 
(Ingraham etal. 1988) and 1 porcine cDNA Pit-1 probe (Tuggle etal. 1993). Plaque 
lifts onto nitrocellulose membranes (Schleicher and Schuell, Keene, NH, USA), were 
done following the recommended protocols for use with lambda library screenings 
and hybridizations (CLONTECH, Inc., Palo Alto, CA,USA). Washes were once in 
2X SSC and 0.1% SDS at room temperature and twice in 0.2X SSC and 0.1% SDS 
at 65° C for 15 min. 
Phage DNA, prepared from selected clones, was characterized by restriction 
endonuclease mapping {Apal, BamH\, Bgl\\, EcoRI, HindW, Hinfi, Kpnl, A/col, PvuW, 
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Sad, Sail, Smal, Tth\M,Xba\, and Xho\) and Southern blot analysis using 5', 3' and 
full-length swine Oct-2 probes and a full-length human Qct-2 probe (Ko eta!., 1988). 
Restriction fragments corresponding to positive Oct-2 Southem banding patterns 
were subcloned into pGEM-5Z (Promega, Inc., Madison, Wl, USA) or pBluescript 
KS+ (Stratagene, La Jolla, CA, USA) and sequenced. 
cDNA synthesis 
A FastTrack™ version 3.2 mRNA Isolation Kit (Invitrogen, San Diego, CA, USA) 
was used to prepare polyCA)* RNA from male White Leghom chicken tissues (bursa, 
spleen, liver and thymus). Reverse transcription was perfomied as follows: one |j.g 
of spleen poly(A)* RNA was brought up to 16.5 ^1 with water and heated to 65° C for 
5 min. Mixed in a separate tube were 20 fil of 5X AMV reaction buffer (Promega), 
10 (xl 100 mM DTT, 2 |ii random primer (Boehringer Mannheim, Indianapolis, IN, 
USA), 2.5 mM dNTPs (Boehringer Mannheim) and 20 U RNasin (Promega). The 
RNA and AMV Reverse Transcriptase (RT; 5 U/ l^; Promega) were added, and the 
tube contents were mixed well and incubated for 90 minutes at 37° C. The cDNAs 
were purified by phenol/ chiorofomri extraction and ethanol precipitation and 
resuspended in 20 |al of TE. 
PCR conditions 
Three |il of the synthesized cDNA sample or 10 ng of the lambda genomic DNA 
were amplified in a 50-|il reaction containing 5 |j.l 10 X buffer (Promega), 3.5 mM 
MgClj, 1.25 mM dNTP's, 2.5 U Taq polymerase (Promega) and 1.5 [ig of each POU 
domain degenerate primer (TT(T/C) AA(A/G) (C/G)(A/T)I (A/C)GI (A/C)GI ATI 
AA(A/G) (C/T)TI GG; (C/T)TG IC(T/G) l(C/T)(G/T) (G/A)TT (A/G)CA (A/G)AA CCA 
lAC; He et al., 1989). The PCR profile was 94° for 4 minutes for 1 cycle; 94° for 1 
minute, 51° for 2 min., and 72° for 3 min. for 40 cycles and 72° for 5 min. for 1 cycle. 
The PCR product was subcloned by using the pGEM-T vector system 
(Promega) following the manufacturer's instructions. Subclones were sequenced by 
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using universal and reverse primers (DNA Sequencing and Synthesis Facility, Iowa 
State University, Ames, lA, USA). 
Mapping Southern blots 
Six |jg of PvuW (Promega) digested DNA from the East Lansing chicken genome 
mapping reference population (Crittenden etal., 1993) was electrophoresed through 
a 0.8% agarose gel (1.3 V/cm) for 41 h. DNA fragments remaining on the gel were 
>500 bp. Southern transfers were done onto Hybond N+ (Amersham, Arlington 
Heights, IL, USA) following manufacturer's directions. DNA was fixed to the 
membrane by exposure to 0.12 J/cm2 of ultraviolet light (254 nm) in a UV 
Stratalinker 2400 (Stratagene). Sad, Taq\ and parental screening blots (Psfl, 
PvuW, Taq\, HindWl, EcoR\, Sad and SamHI) were previously prepared by Spike et 
al. (1996). 
Computer analysis 
DNA and amino acid sequence data analysis were conducted using the 
University of Wisconsin Genetics Computer Group's sequence analysis software 
package (Devereux etal. 1984). Sequencing results were analyzed by using 
Sequence Navigator (Applied Biosystems). 
Results 
Genomic clone isolation 
The chicken liver genomic library (Clontech) contained 1.7 x 10® recombinants 
with insert sizes ranging from 8 to 21 kb. Approximately 164 000 plaques were 
screened by using mixed, multiple POU domain probes {Oct-1, Oct-2 and Pit-1). 
From this initial screen, 78 positive samples were collected and used in a secondary 
screen. The 78 samples were randomly combined into 24 pools (three or four 
samples per pool) and plated at 30 000 pfu per 150 mm plate. Filters fi-om these 
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plates were hybridized with only the Oct-2 probes. Six clones were chosen for 
further characterization on the basis of prinnary and secondary hybridization with 
Oct-2 probes alone. 
Phage DNA from six genomic clones (clones 6, 7, 11, 39,42 and 68) was 
subjected to restriction enzyme mapping and Southem blot analysis using 5', 3' and 
full-length swine Oct-2 probes and a human full-length Oct-2 probe. Of the original 
six genomic clones, clones 6 and 11 and clones 42 and 68 gave identical restriction 
enzyme pattems. Because the two clones within each pair were expected to be very 
similar or identical, only one clone from each pair (11 and 68) was chosen for further 
analysis. An approximately 1000-bp A/col fragment, a fragment that hybridized to an 
Oct-2 probe, was subcloned from genomic clone 11 and sequenced. Sequence 
comparisons showed high homology to class II POD genes in the coding region, 
most highly to rat Skn-1, mouse Oct-11 and mouse Epoc-t(DNA - 74% across 130 
bp of coding sequence). 
Genomic clone PCR 
PGR using POU-domain degenerate primers was used to determine the 
presence of the POU domain in genomic clones 7, 11, 39 and 68. The primers were 
designed to amplify most of the conserved POU domain. PCR of genomic clones 7 
and 11 resulted in an amplified product of approximately 1000 bp. The clone 11 
PCR product was subcloned and sequenced (Accession #: U77715). Sequence 
from the clone 11 PCR-amplified POU domain showed homology to class II POU 
genes with the highest homology to rat Skn-1, mouse Oct-11 and mouse Epoc-1. 
The sequence from the previously subcloned Nco\ fragment overiapped by 27 bp 
with the PCR fragment and added additional 3' flanking sequence to the POU 
domain. 
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Oct-11/Epoc-1/Skn-1 mapping 
The two newly cloned POU fragments were used together to screen the 
parental DNA in both the East Lansing and Compton chicken gene mapping 
reference populations for polymorphisms (Bumstead and Palayga 1992; Crittenden 
etal. 1993). The restriction enzymes tested were Psti, PvuW, Taq\, HindlW, EcoR\, 
Sad and SamHI. A Sad polymorphism in the East Lansing reference family was 
the only polymorphism identified. Epoc-1/Oct-11/Skn-1 was mapped to linkage 
group E49 (Fig. 1). 
RT-PCR 
RT-PCR was done using POU domain degenerate primers with bursa and 
spleen mRNA. An approximately 400-bp fragment resulting from amplification of the 
spleen mRNA was subcloned and sequenced (Accession #: U77642). The PCR-
amplified POU domain subclone showed high sequence homology to human Bm-3a 
(DNA - 93%, amino acid -100%). 
Brn-3 mapping 
The Bm-3 subclone identified one PvuW polymorphism in the East Lansing 
genome mapping reference population, but none in the Compton mapping 
population. PvuW blots of the East Lansing mapping reference population progeny 
were hybridized with the Bm-3 POU domain cDNA (Fig. 2). The Bm-3 POU domain 
mapped to linkage group E48. 
Discussion 
We have identified two new POU domain genes in the chicken. Petryniak et al. 
(1990) suggested that at least 6 to 10 members of the POU family of genes exist in 
the chicken. They identified the ubiquitously expressed Oct-1 gene. The chicken 
Oct-1 POUs and POUHD were 100% conserved with human Oct-1. This 
conservation of sequence homology over such a large phylogenetic distance 
55 
suggests that these domains perfomi an important biological function. The newly 
identified chicken POU domains also show a high degree of sequence homology 
across species, further supporting the importance of the POU domain in chickens, 
as well as in mammals. 
Oct-1 is a member of the class 11 POU genes. Other genes In this class include 
Oct-2, EpoC'1/Skn-1 and Oct-11. We have identified a POU domain with homology 
to Epoc-1/Skn-1/Oct-11. The genomic fragment encompasses most of the POU 
domain and a short region of the 3' flanking sequence (2341 bp). There are four 
Introns and four exons. The intron/exon junctions of the presumed cDNA closely 
match with those previously described for this region in Oct-2 (Matsuo et al. 1994). 
Epoc-1 and Skn-1 have been Identified as the same gene independently 
isolated in different species, mouse and rat, respectively. Epoc-1 and Oct-11 are 
identical with the exception of their cariaoxy terminus, with Epoc-1 being 28 a.a. 
longer. This difference suggests that Oct-11 may be a differentially spliced product 
from the same gene, a mechanism seen In generating multiple isoforms of Oct-2. 
Epoc-1 and Skn-1 can transcriptionally activate the cytokeratin 10 (K10) promoter 
gene expression, binding an octamer-like recognition site (Andersen etal. 1993; 
Yukawa etal. 1993). 
The chicken Epoc-1/Skn-1/Oct-11 gene was mapped to linkage group E49 in 
the East Lansing reference mapping population. Other members of this linkage 
group Include the apolipoproteln A1 {ApoAl) gene and the autosomal white (W) skin 
allele (Crittenden etal. 1993; Smith etal. 1996). This linkage group represents a 
conserved syntenic group with mouse and human (Fig. 3). ApoAl maps to 11q23.3 
and chromosome 9 in human and mouse, respectively. Goldsborough and 
cowori^ ers (1993) Identified Oct-11 In the mouse and mapped the gene to the 
syntenic region of mouse chromosome 9 conserved to human chromosome 11q23. 
Additionally, Skn-1 was mapped to chromosome 9 In the mouse (Xia etal. 1993). 
POU domain genes from all classes are expressed in the mammalian brain. He 
and coworkers (1989) identified the Bm-3 family of proteins, members of the class 
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IV POU proteins. Three different Bm-3 genes have been identified in mouse, rat 
and human. They include S/77-3a (Collum ef a/. 1992; Gerrero ef a/. 1993; Lillycrop 
et at. 1992), Bm-3b (Lillycrop etal. 1992; Tumer etal. 1994) and Bm-3c (Gerrero et 
a/. 1993; Ninkina ef a/. 1993). Using POU domain degenerate primers in RT-PCR, 
we identified a chicken Bm-3 POU domain cDNA from spleen mRNA. The cDNA 
shows highest homology to Bm-3a (DNA - 93%, amino acid -100%). Two 
unpublished chicken Bm-3 sequences in GenBank (Accession #: X91998, X91997) 
showed lower levels of homology to the chicken Bm-3a POU domain isolated here 
(DNA - 82%) than the homology to mouse (DNA - 92%) and human Bm-3 clones. 
This suggests that there may be multiple Bm-3 genes in the chicken as was seen in 
other species. Because of high homology, we propose that the clone we isolated is 
chicken Bm-3a. 
The Bm-3a cDNA identified was mapped in the East Lansing chicken reference 
mapping population to linkage group E48. Cdx-1 {Chox-Cad, Fmmkin et al. 1991) is 
the only other gene currently located in this linkage group. Cdx-1 has been mapped 
to human chromosome 5q31-q33 (Bonner et al. 1995). Bm-3a has been mapped to 
mouse chromosome 14E1-3 (Thiel etal. 1994) and human chromosome 13 (Collum 
etal. 1992). 
The conserved homology of the two newly identified POU domain genes in the 
chicken supports the importance of this domain and family of genes. It also 
suggests that these genes may play a transcriptional regulatory role in the chicken 
as is seen in other species because of the conservation of the crucial DNA binding 
domain. Bm-3a and Epoc-I/Skn-I/Oct-11 genes were mapped to separate linkage 
groups with the identification of a chicken syntenic group conserved with mouse and 
human. 
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Figure 2. Southem blot of PvuW polymorphism in East Lansing reference 
population labeled with chicken 8m-3a. The 5.6-Kb fragment from the F1 
sire segregates in his progeny. 1, Inbred White leghom GHs: 2, Jungle fowl 
X White Leghom F1 sire: 3, 17-18, White leghom dams: 3-7, 9-16 progeny, 
8, Lambda BSTOI marker. 
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CHAPTER 4. TISSUE EXPRESSION PATTERNS OF CHICKEN 
OCTAMER-BINDING PROTEINS 
A paper to be submitted to DNA and Cell Biology 
Heltemes, L.M.\ C.K. Tuggle^ and S.J. Lamonf-^ 
ABSTRACT 
We examined octamer-binding protein expression pattems in multiple chicken 
tissues. Octamer-binding protein complexes were found in ovary, cerebrum, liver, 
lung, kidney, spleen, thymus, bursa, MSB1 (T cell line), and DT40 (B cell line). 
Every tissue had at least two octamer-binding proteins. The total number of 
different protein-DNA complexes identified was seven. A comparison between 
mouse and chicken octamer-binding proteins resulted in the identification of a 
unique octamer-binding protein. Chicken Oct-1 was expressed in all chicken tissues 
tested except for liver. Our results indicate that multiple octamer-binding proteins 
exist in the chicken. 
INTRODUCTION 
The sequence-specific interaction between frans-acting proteins and c/s-acting 
DNA elements is the foundation of transcriptional regulation (Hatzopoulos etal., 
1990). One well-recognized c/s-acting DNA element Involved in both tissue-specific 
and ubiquitous gene expression is the octamer motif (ATTTGOAT; Kemler and 
Schaffner, 1990). The importance of the octamer motif has been demonstrated in 
both the promoter and enhancer regions of the mammalian immunoglobulin genes 
Program of Immunobiology^ and Department of Animal Science^, Iowa State 
University, Ames, lA 50011 
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(Dreyfus etal., 1987; Wirth etal., 1987) and the mammalian snRNA genes (Tanaka 
et ai, 1988). The octamer motif has also been shown to be important in the 
enhancer of both the chicken U1 and U4B snRNA genes (Zamrod and Stumph, 
1990; Cheung ef a/., 1993). 
Several octamer-binding factors have been identified (Wegner et ai, 1993), 
including a tissue-specific factor, Oct-2 (MQIIer et al., 1988) and a ubiquitously 
expressed factor, Oct-1 (Sturm etal., 1988). In the mouse, approximately ten 
octamer-specific proteins have been identified (Scholer ef a/., 1989; Scholer, 1991). 
These proteins are not only expressed in the mouse during postnatal development, 
but are differentially expressed during embryogenesis (Scholer et al., 1989). 
Additionally, the proteins have been identified in a variety of tissues. To date, the 
isolated octamer-binding proteins all belong to the POU family (Scholer, 1991). 
The Electrophoretic Mobility Shift Assay (EMSA) can be used to examine 
interactions between DNA elements and transcription factors (tissue expression 
patterns of DNA binding proteins). It Is based on the principle of DNA-protein 
interactions altering the mobility of DNA fragments in electrophoresis. EMSA is 
useful in studying interactions of proteins with specific DNA sequences. Proteins of 
different molecular weights may bind the same DNA sequence, which will result in 
differences in migration. Although multiple octamer-binding proteins have been 
identified in the mouse, little is known about the extent of these proteins in another 
developmental model species, the chicken. In this study, we examined the 
expression pattern of octamer-binding proteins in multiple tissues and cell lines of 
the chicken. 
MATERIALS AND METHODS 
Cell Lines 
Two chicken lymphocyte lines, DT40 (B cell line; Baba etal., 1985) and MSB1 
(T cell line; Akiyama and Kato, 1974) were received from Dr. Craig Thompson, 
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University of Chicago. They were cultured in Oulbecco's Modified Eagle's Medium 
(DMEM) with 10% newbom calf semm and 5% chicken serum at 42° C with 5% 
CO2-
Tissue Samples 
White Leghorn chicken tissues O'uvenile (<12 weeks); whole blood, cerebrum, 
ovary, thymus, liver, spleen, kidney, bursa, and lung) and mouse tissues (day 15 
embryo [d15]) were removed using aseptic techniques, immediately frozen in liquid 
nitrogen and stored at -70° C. 
Cell Extracts 
Whole ceil extracts from the tissues were isolated by the technique of 
Deryckere and Gannon (1994). The technique used to isolate whole cell extracts 
from the cell lines was a modification of DIgnam and coworkers (Dent and 
Latchman, 1993). HeLa nuclear extracts were purchased from Promega (Madison, 
W! USA). Mouse embryo day-12.5 nuclear extracts (Tammy Nowling, Iowa State 
University) were also used. Protein concentrations were determined by using the 
Bio-Rad protein assay (Blo-Rad, Hercules, CA USA). Extracts were aliquoted and 
stored at -70° C. 
Probes and Competitor DNA 
Multiple octamer oligonucleotides were used (Figure 1). The mouse octamer 
oligonucleotides were annealed by adding equal molar amounts of each 
oligonucleotide, heating to 70° C for 5 minutes and cooling to room temperature. 
The overhang was then filled In by adding dNTPs and Klenow fragment (Promega) 
and incubating at 37° for 15 minutes. The annealed oligonucleotides were then 
dephosphorylated by using shrimp alkaline phophatase (SAP; United States 
Biochemical, Cleveland, OH USA) following the manufacturers recommended 
conditions. The oligonucleotide was phenol/chloroform extracted, ethanol 
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precipitated, and resuspended in water. Oct-1 consensus oligonucleotide (Figure 1, 
A) was purchased (Santa Cruz Biotechnology, Santa Cruz, CA USA). Two 
complementary oligonucleotides were designed from the published chicken 
immunoglobulin promoter sequence (McCormack et ai, 1989; Petryniak et al., 
1990) and synthesized (Nucleic Acid Facility, Iowa State University, Ames, lA 
50011). These latter oligonucleotides encompassed the immunoglobulin promoter 
octamer motif and some flanking sequence (Figure 1). A mutant form of the same 
oligonucleotide was also created. The mutant oligonucleotide was designed by 
excluding the six intemal base pairs of the octamer motif (Figure 1, B). A mutant 
oligonucleotide was also purchased (Figure 1, B - Santa Cruz Biotechnology). The 
mutant changed the last two base pairs of the octamer from AT to GC. 
EMSA 
DNA fragments were end-labeled by using T4 polynucleotide kinase following the 
manufacturer's guidelines. The labeled octamer oligonucleotide was then run 
through a Bio-Spin column (BioRad) to remove unincorporated nucleotides. The 
sample (0.5 to 2.0 ng of labeled oligonucleotide, 1 |jg poly [dl-dC»dl-dC], 1 to 5 ^g of 
protein extract [25% glycerol, 29 mM HEPES pH 7.9, 420 mM NaCI, 1.2 mM MgClj, 
0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF, 2 mM Benzamidine, and 5 pg/pl 
pepstatin, leupeptin and aprotinin]) was brought to a final volume of 20 pi with 
sample buffer (lOmM Tris, 50 mM NaCI, 1 mM DTT 1 mM EDTA and 5% glycerol) 
and incubated for 20 minutes at room temperature. The sample was loaded on a 
5% polyacryiamide gel (29 acrylamide : 1 bis-acrylamide). Loading dye was used in 
one lane as marker. The gel was mn at 150 V until the dye front was 2.5 cm from 
the bottom of the gel (between 2 and 2.5 hours). The gel was then vacuum dried on 
Whatman paper and exposed to x-ray film. 
Competition assays were done in the same way, except that 100 ng of 
unlabeled, annealed oligonucleotide was added to the reaction mixture. 
Supershift assays were done by preincubating 1|ag of anti-Oct-1 antibody (Santa 
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Cruz Biotechnology) with cell extract and incubating for 30 minutes at 4° C. The rest 
of the assay was performed as previously described. 
RESULTS 
Multiple EMSAs were perfomned to determine the expression pattems of 
octamer-binding proteins in different tissues of the chicken. Multiple 
oligonucleotides (Figure 1) containing the octamer motif were used as the labeled 
binding fragment, and whole cell extracts were isolated from chicken tissues and cell 
lines, including immune and nonimmune tissues. Mouse embryo (day 12.5 and 15) 
and HeLa cell extracts were used as controls for previously identified mammalian 
octamer-binding proteins. No differences in octamer-binding pattems were noted 
among any of the three different oligonucleotides. 
A chicken B-cell line (DT40) and a chicken T-cell line (MSB1) were used as 
references for putative chicken Oct-1 and Oct-2 proteins. These cell lines were 
previously used by Petryniak et al. (1990), who cloned chicken Oct-1, to show that 
DT40 B cells contained an Oct-2-like octamer-binding protein that was not present in 
MSB1 T cells. In their EMSA wori<, there were two bands in DT40 extract and one 
band in MSB1 extract. We demonstrate the existence of three bands in DT40 
extracts and just the one band in MSB1 extracts. The band common to both extracts 
is that of the putative Oct-1 octamer-binding protein (Petryniak etai, 1990; Figure 
2). 
The tissues or cell types used in the EMSA were B cells, T cells, blood, 
cerebrum, ovary, thymus, liver, spleen, kidney, bursa, and lung. The EMSA showed 
differences in DNA binding to octamer-binding proteins in chicken tissues. It 
showed that there must be tissue-specificity in expression of octamer-binding 
proteins in the chicken. Figure 3 is a schematic presentation of the combined EMSA 
results and figure 4 is an example of a typical, single assay result. 
Competition assays were perfonned to detemriine if the bands were a result of 
specific or nonspecific DNA binding. Competitor oligonucleotides (regular and 
67 
mutant) were added to the binding reaction to compete away protein interactions 
with labeled DNA (Figure 2). Results indicated that most of the bands seen in the 
EMSA are specific binding interactions with the octamer oligonucleotide and not just 
an interaction with random DNA. 
Another modification of the EMSA, the supershift assay, was used to identify 
which of the multiple complexes was the Oct-1-DNA interaction. By adding specific 
antibody to the reaction mix with the protein and DNA, the supershift assay utilizes 
the interaction between protein and antibody either to decrease the normal 
migration of the DNA-protein interaction (supershift) or to interfere with the 
interaction between protein and DNA. The addition of the a-Oct-1 antibody resulted 
in a shift of the top band in the HeLa cell extract, and chicken B and T cells (Figure 
5). This is the same band identified by previous researchers (Petryniak etal. 1991) 
as being present in extract from both DT40 (B cells) and MSB-1 (T cells). 
DISCUSSION 
The results of the electrophoretic mobility shift assay demonstrate the binding of 
chicken proteins to the octamer motif. The octamer motif is found in some 
transcriptional regulatory sequences (promoters and enhancers). Three different 
octamer oligonucleotides were used in which the octamer sequence was identical 
but the flanking sequences were different. We were unable to detect any 
differences in banding pattern among any of these oligonucleotides (Data not 
shown). Petryniak and coworkers (1990) found no differences in banding patterns 
between the full immunoglobulin lambda light chain promoter and the shortened 
oligonucleotide used in their research. This suggests that binding occurs only at the 
octamer site and not in regions of the flanking sequence. It is possible, however, 
that there are interactions also important to transcriptional activation via the octamer 
site that require other interactions not being detected with these oligonucleotides. 
These interactions could include protein-protein interactions with octamer-binding 
proteins that require specific flanking sequences. 
68 
The EMSA results identified differences in tissue-expression patterns for 
chicken octamer-binding proteins. Expression differences in octanner-binding 
patterns have also been demonstrated in other species (Scholer et al., 1989; 
Scholer, 1991). Specificity of DNA-binding was shown by using mutated binding 
sites in the octamer motif in competition assays. There were seven octamer-binding 
proteins identified in the chicken tissues examined. Many of these are expressed in 
multiple tissues, with the exception of one liver protein. Only one band, identified as 
Oct-1, is ubiquitously expressed. It cannot be determined from this assay whether 
these binding reactions (bands) represent separate genes or distinct proteins 
created from the same gene (altemative splicing). 
In mammals, octamer-binding proteins have been numbered in sequential order 
starting with the slowest migrating DNA-protein complex (Oct-1). According to 
banding patterns for octamer-binding proteins in other species, the top band seen in 
chickens (Figure 1) would likely represent Oct-1 and the second band, Oct-2. 
Supershift assays, by using a-Oct-1 antibody, verified the designation of the top 
band as Oct-1 (Figure 5). 
Comparison of octamer-binding patterns in the chicken with those of mammals 
shows both similarities and differences. There is no DNA-protein complex with a 
migration pattern identical to mouse Oct-2. However, there is a faster-migrating 
protein-DNA complex which is present only in the B cell line, bursa and brain, the 
expression pattem predicted by Oct-2 expression in mammals. Additional 
differences exist in the octamer-binding pattems between chicken and mouse. The 
chicken liver has a protein-octamer complex larger in size than the Oct-1 complex 
and also one smaller in size. The larger complex is found only in liver, but the 
smaller complex is found in all tissues but not in the lymphoid cell lines. This is in 
contrast to the mouse, in which only Oct-1 protein was detected in the liver (Scholer, 
1989). There is a band in chicken tissues that displays slightly faster mobility than 
mammalian Oct-2. This band is found in most chicken tissues and may represent a 
different, unique migration pattern, and possibly chicken-specific octamer-binding 
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protein. 
Though fewer in number than in mammals, multiple octamer-binding proteins 
exist in the chicken and display differential tissue expression pattems. It has 
already been demonstrated that the octamer motif is important in the chicken in the 
enhancer region of chicken U1 and U4B snRNA genes (Zamrod and Stumph, 1990; 
Cheung etal., 1993) and in recombination in Immunoglobulin genes (Bulfone-Paus 
et ai, 1995). In the chicken snRNA enhancer, the octamer motif is required for 
functional activity of the enhancer. It seems that the octamer motif, in the enhancer 
region of the immunoglobulin genes, participates in silencer activity in the chicken. 
This silencer activity helps to regulate gene expression from Immunoglobulin genes 
that are not rearranged in the chicken. 
We demonstrated the ubiquitous expression pattem of Oct-1 in the chicken as 
well as the existence of multiple tissue-restricted octamer-binding proteins. Not only 
Is the Oct-1 protein sequence highly homologous (Petryniak etal., 1990) to that of 
mammals but the expression pattem, therefore, is also very similar. We identified 
the existence of octamer-binding protein with a migration pattem different than any 
seen in the mouse. Additionally, we established the existence of tissue-specific 
octamer DNA binding patterns for the chicken. This research has demonstrated the 
presence of multiple octamer-binding proteins in the chicken. 
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Figure 1. Sequence of normal and mutated octamer oligonucleotides. The top strand of each oligonucleotide 
is shown. (A) Oligonucleotide sequences aligned by the octamer sequence (ATTTGCAT). Sequence from 
chicken immunoglobulin lambda light chain promoter. Oct-1 oligonucleotide from Santa Cruz Biotechnology. 
Mouse octamer oligonucleotide. (B) Comparison of regular oligonucleotide with mutated oligonucleotide. The 
first sequence represents the normal sequence with the mutated nucleotides in lower case letters. (1&2) 
Chicken immunoglobulin lambda light chain oligonucleotide. (3 & 4) Santa Cruz Biotechnology Oct-1 
oligonucleotide. 
A. Octamer Oligonucleotides 
1) 5' G CGC AGG GAG TTA TTT GCA TAG GGG GGC GTC 3' 
2) 5' TTC TAG TGA TTT GCA TTC GCC A 3' 
3) 5' TGT TAA TTT GCA TTT CTA A 3' 
B. Mutant octamer Oligonucleotides 
1) 5' G CGC AGG GAG TTA ttt gca TAG GGG GGC GTC 3' 
2) 5' G CGC AGG GAG TTA TAG GGG GGC GTC 3' 
3) 5' TTC TAG TGA TTT GCA TTC GCC A 3' 
4) 5' TTC TAG TGg aTT GCA TTC GCC A 3' 
Figure 2. Competitor assay for MSB1 and DT40. The lane labeled oligo demonstrates the results of running the 
labeled oligo without any extract (negative control). Oct-1 is the top band while the other bands are unknown 
octamer binding proteins. 
Oligo DT40 MSB1 
+ - Specific Comp. 
+ Nonspecific Comp. 
> Oct-1 
Figure 3. Schematic of tissue expression of chicken octamer-binding patterns, human HeLa cell extract and 
mouse day 15 embryo extract. The bands represent only the specific bands seen except for ovary and cerebrum 
(competitor assays were not done). Positions of mammalian Oct-1 and Oct-2 are indicated, as well as 
oligonucleotide. 
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Figure 4. An assay demonstrating the octamer-binding protein patterns for multiple tissues including: bursa, 
spleen, thymus, kidney, liver, lung, cerebrum, ovary and mouse embryo (d15). 
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Figure 5. Antibodies to Oct-1 change confiplex mobility and demonstrate the presence of Oct-1 in chicken B 
(DT40) and T (MSB1) cells. HeLa cell extract was used as a positive control and the mouse d15 embryo was 
included to show relative positions of additional bands. 
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CHAPTER 5. TRANSCRIPTIONAL ACTIVITY OF CHICKEN LAMBDA 
IMMUNOGLOBULIN LIGHT CHAIN PROMOTER IS DEPENDENT ON 
INTACT OCTAMER MOTIF AND ENHANCER SEQUENCE IN B 
LYMPHOCYTES 
A paper to be submitted to Immunogenetics 
Lynn M. Heltemes\ Christopher K. Tuggle^, and Susan J. Lamont '^^  
Abstract 
The chicken immunoglobulin lambda light chain promoter contains an octamer 
motif (-106) and a TATA box (-70). Two lymphoid cell lines, DT40 (B-cell line) and 
MSB1 (T-cell line), were used to test the activity of the germline promoter and the 
function of the octamer motif. The promoter was functional only in B-cells in the 
presence of SV40 enhancer. Mutation of the octamer motif eliminated the 
transcriptional activity of the immunoglobulin promoter. These results suggest that 
the chicken immunoglobulin promoter functions similarly to mammalian 
immunoglobulin promoters in that it plays a role in tissue specificity and requires 
both an enhancer and an intact octamer motif for activity. 
Introduction 
The gemnline structure of the immunoglobulin genes in the chicken is quite 
different from that of mammals. In the chicken, there is only one variable and one 
joining segment in both the lambda light chain and the heavy chain genes (Reynaud 
etal. 1985; Reynaud etal. 1983). The variable segment is preceded by multiple 
Program of Immunobiology and ^ Department of Animal Science, Iowa State 
University, Ames, lA 50011 USA 
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pseudogenes used to create diversity through intrachromosomal gene conversion 
(Reynaud etal. 1987, 1989; Thompson etal. 1987; Review: Thompson 1992). 
Little information is available about the control of expression of immunoglobulin 
genes in the chicken. In mammals, it has been established that the immunoglobulin 
promoter plays an important role in the transcriptional regulation and in tissue-
specificity of immunoglobulin gene expression (Queen etal. 1986; Wirth etal. 1987; 
Dreyfus et al. 1987). Two sequence motifs, the octamer motif (ATTTGCAT) and the 
TATA-box (TATAA), which are important for immunoglobulin gene expression, have 
been identified in mammals (Parslow etal. 1984; Falknerand Zachau 1984; 
Bergman etal. 1984; Queen and Stafford 1984). The TATA-box is located 30 bp 
upstream from the initiation site, and the octamer motif is found 70 bp upstream 
from the initiation site. In the chicken lambda light chain promoter, the TATA-box is 
located 70 bp upstream from the initiation site, and the octamer motif is found 106 
bp upstream from the transcriptional initiation site (Reynaud etal. 1983; 
McCormack etal. 1989). 
In this study, we examined the function of the chicken immunoglobulin 
lambda light chain promoter, both with and without an SV40 enhancer sequence, in 
two chicken lymphoid cell lines, a B-cell line and T-cell line. Additionally, we 
mutated the octamer site by altering two of the eight DNA base pairs within the 
conserved sequence to detennine the importance of the octamer motif in chicken 
immunoglobulin promoter activity. 
Materials and methods 
Cell Lines 
DT40 (B-cell line; Baba etal. 1985) and MSB1 (T-cell line; Akiyama and Kato 
1974) cells were obtained from Dr. Craig Thompson, University of Chicago. Both 
cell lines are virally transformed chicken lymphoid cell lines. They were cultured in 
DMEM (Sigma) with 10% newbom calf serum (Sigma) and 5% chicken serum 
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(Sigma). Cells were cultured in 75 cm^ flasks in preparation for transfection. 
Reporter constructs 
Lambda light chain immunoglobulin promoter DNA fragments were generated by the 
polymerase chain reaction (PGR). The full-length immunoglobulin lambda light 
chain gene (accession #: M24403), kindly provided by Dr. Craig Thompson 
(University of Chicago), was used as a template. PCR primers were designed to 
amplify a 466 bp fragment from -466 to the start site, 1 (5' GCA GOT GGT TCA 
AAG AAA CGT 3'; 5' GGC GGA ATC CCA GCA GCT GT 3'). The reaction 
conditions were 94° C for 4 min; 30 cycles of 94° C, 1 min; 58° C, 45 sec; and 72° C 
and an extension at 72° C for 10 min. The reaction buffer included 10 ng of 
template, IX reaction buffer, 50 pM of each primer, 0.2 mM dNTR, 1.5 mM MgClj, 
and 1.25 U Taq polymerase (Promega, Madison, Wl). 
All PCR products were first subcloned by the pGEM-T cloning system 
(Promega) according to the manufacturer's instructions and sequenced (DNA 
Sequencing and Synthesis Facility, Iowa State University, Ames, lA). From the 
pGEM-T vector, the insert was removed by digestion with Sph\ and Sail. The 
immunoglobulin promoter fragment was electrophoresed into an agarose gel and 
the fragment was eluted from the agarose gel slice through a filtered pipet tip (Dean 
and Greenwaid 1995). The fragment was then subcloned into pCAT-Basic (pCAT-
B; Promega) and designated as pCAT-B+lgP. From pCAT-B, the immunoglobulin 
fragment was also moved to pCAT-Enhancer (pCAT-E, Promega) by using the 
H/ndlll and Sail sites and then designated as pCAT-E+lgP. 
pOPRSVI-CAT (Stratagene), a reporter construct with the RSV promoter and 
the CAT gene, and the pCAT-E without a promoter were also used. 
Site-directed mutagenesis 
Site-directed mutagenesis was done as described by Ho etal. (1989). Primers were 
designed to mutate the octamer site (5' CCC CCT ATG AAT ATA ACT CC 3'; 5' 
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GGC GGA ATC CCA GCA GCT GT 3'). The mutations resulted in a change from 
ATTTGCAT to ATATTCAT. The fragment was subcloned as described previously. 
The resulting reporter constmcts, without and with enhancer, are called pCAT-
B+MlgP, and pCAT-E+MlgP, respectively. 
DNA transfection 
Twenty pg of each reporter construct was transfected into DT40 and MSB1 cells by 
electroporation. Twenty |jg of each plasmid, 100 pg of sheared salmon sperm DNA, 
and 10^ cells in 500 pi of PBS were added to a 5mm gap cuvette and Incubated on 
Ice for 10 min. After a 300-V, 500 pF pulse with an Electroporator II (Invltrogen, San 
Diego, CA), the cells were incubated at 4° C for 10 min. One ml of tissue culture 
media was added to the cuvette, and the cells were then transferred to a 60x15 mm 
dish and fed 9 mis of medium. The cells were incubated at 42° C and 5% CO2 for 
48 hours. Cell lysates were prepared by the freeze-thaw method (Gorman et al. 
1982). Protein concentrations of the cell lysates were determined by the Bradford 
method (BioRad, Hercules, CA) 
CAT assay 
The CAT assay was conducted as described by Seed and Sheen (1988); 20 pg 
of cell protein were used and the values given represent the mean of four 
independent transfections. 
Results 
To analyze the function of chicken immunoglobulin X light chain promoter (IgPO, 
multiple plasmid reporter constructs were created with the promoter placed 
upstream of the CAT gene. Additionally, constructs were created with and without 
an SV40 enhancer sequence downstream of the CAT gene. Structural features of 
IgP;,, including an octamer motif and a TATA box, are depicted in Figure 1. 
To detemnine IgP^ activity, two chicken lymphoid cell lines (DT40, B-cell line; 
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MSB1, T-cell line) were transfected with the pCAT-B+lgP and pCAT-E+lgP 
constructs. As negative and positive controls, the cell lines were also transfected 
with pCAT-E (no promoter) and pOPRS-VI-CAT (RSV promoter), respectively. The 
results of the CAT assay showed that the IgPj. was active only in B-cells and 
required the presence of an enhancer sequence (Figure 2a). Both a positive and 
negative control for promoter activity were used. The RSV promoter-driving CAT 
gene expression resulted in consistently high promoter activity in all assays and 
both cell lines, as determined by CAT activity, which demonstrated that both the 
transfection and the CAT assay were functional in both cell lines (Data not shown). 
Transfection with the pCAT-E reporter construct resulted in no CAT activity in any of 
the assays or cell lines (Data not shown). 
To test the importance of the octamer motif in the promoter region in the chicken 
IgPx, constructs were created with a mutated octamer motif, in which the octamer 
motif was changed from ATTTGCAT to ATATTCAT. This changed the octamer site 
to a Plt-1 binding site. None of the reporter constructs with mutated octamer sites 
demonstrated any promoter activity as detennined by CAT activity. The CAT 
assay, using the mutated octamer motif, demonstrated that the octamer motif was a 
necessary component of the IgP^^ (Figure 2b). 
Discussion 
In this study, we examined the ability of the chicken immunoglobulin lambda 
light chain promoter to drive gene expression in two chicken lymphoid cell lines. One 
cell line, DT40, Is a B-cell line, and the other cell line, MSB1, is a T-cell line. The 
activity of the promoter was determined by the ability of the IgPj. to drive CAT gene 
expression. Additionally, we examined the role of the octamer motif by mutating the 
motif to a Pit-1 binding site (Elsholtz etal. 1990). 
Previous research has been conducted using the chicken IgP^ to examine the 
role of this sequence in immunoglobulin gene expression. Lauster and coworkers 
(1993) identified a functional role for the IgP;^ in rearrangement of the 
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immunoglobulin gene. This work was done in mouse cell lines rather than chicken 
cell lines and examined gene rearrangement rather than gene expression. CAT 
assays used to identify regions of importance in immunoglobulin gene 
rearrangement demonstrated slight promoter activity in a mouse pre-B-cell line with 
the IgPx and an SV40 enhancer. Bulfone-Paus etal. (1995) also identified some 
lgP;^^ promoter activity with the immunoglobulin enhancer sequence, in studying 
promoter sequence function in immunoglobulin gene rearrangement. In both 
instances, research focused used a transgenic mouse model in which the chicken 
immunoglobulin transgene has been shown to rearrange (Bucchini etal. 1987). 
Research to date on chicken immunoglobulin gene rearrangement has been 
conducted in the mouse and demonstrates how the IgPj^  functions in the mouse 
cellular environment. Octamer-binding proteins in multiple chicken tissues display 
differences in the patterns of tissue expression of octamer-binding proteins between 
mammals and birds (Heltemes, Tuggle and Lament, unpublished data). Therefore, it 
is possible that studying chicken gene expression in the chicken will provide a less 
complicated and more specific system in which to elicit mechanisms controlling 
immunoglobulin gene expression in chickens. 
The chicken lambda light chain immunoglobulin promoter activated the CAT 
gene in the B-cell, but not the T-cell line and only in the presence of an enhancer 
sequence, as the results from mammalian research would predict (Bergman et al. 
1984; Falkner and Zachau 1984; Parslow efa/. 1984). The IgP;^ sequence is, 
therefore at least partly responsible for the tissue specificity of immunoglobulin gene 
expression because the expression was limited to B lymphocytes. In addition, the 
IgP;,^ was demonstrated to be capable of driving transcription in the DT40 cell line 
and that an enhancer sequence is a necessary component of the transcriptional 
regulation of the immunoglobulin lambda light chain gene. The enhancer sequence, 
however, need not be the immunoglobulin enhancer, a finding similar to that 
demonstrated in mammals (Grosschedl and Baltimore, 1985). The SV40 enhancer, 
in concert with the SV40 promoter, results in low activity in both cell lines (Heltemes, 
89 
Tuggle, and Lament, unpublished data). Together with the results from the chicken 
IgF').' this suggests that nonspecific interactions at the enhancer region require 
tissue-specific interactions in the promoter sequence. 
It us well established that the octamer motif is a necessary component of the 
regulation of mammalian immunoglobulin gene expression (Bergman etal. 1984; 
Falkner and Zachau 1984). To test this in the chicken, we performed site-directed 
mutagenesis of the octamer motif changing it from ATTTGCAT to ATATTCAT. This 
represented a change to a Pit-1, a POU transcription factor, binding site. Elsholtz 
and coworkers (1990) demonstrated that a change from the Pit-1 site to the octamer 
motif was sufficient to switch specific binding activity at this site. Further, Lauster et 
al. (1993) demonstrated the necessity of the immunoglobulin enhancer octamer 
motif In the chicken immunoglobulin gene rearrangement by deleting the six intemal 
base pairs of the octamer motif. Mutation of the octamer motif in the promoter 
region of the chicken IgP;^ 9©"® demonstrated the necessity of the octamer motif for 
chicken IgP^, activity. In the presence or absence of the enhancer sequence, no 
transcriptional activity was detected in either cell line with the mutated octamer motif 
in the promoter. This demonstrates the importance of both the octamer motif and 
the two specific bases. Additionally, it demonstrates that the enhancer sequence 
does not function with all promoter sequences in the B-cell line, but has limited 
specificity. 
Though immunoglobulin gene rearrangement mechanisms are different 
between mammals and chickens, it seems that immunoglobulin gene expression 
mechanisms may be very similar. We identified the participation of the IgPj^  in the 
tissue-specific expression of chicken immunoglobulin genes. We also demonstrated 
that the promoter sequence is capable of driving CAT gene expression in the 
presence or an enhancer sequence. The enhancer sequence does not need to be 
the immunoglobulin lambda light chain gene enhancer. The octamer motif is a 
crucial component for function of the chicken IgP;^ segment. Mutation of the octamer 
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motif sequence resulted in complete inactivity of the construct that was active before 
mutation. 
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Figure 1. The reporter constructs for the chicken immunoglobulin X light chain promoter. The octamer motif, 
TATA box, CAT gene, and SV40 enhancer sequences are indicated. pCAT-B+lgP represents the pCAT-Basic 
reporter plus the immunoglobulin promoter, and the pCAT-E+lgP represents the same construct but also includes 
the SV40 enhancer. The pCAT-B+MlgP and pCAT-E+MlgP are the same as the previously described constructs, 
except that the octamer motif has been mutated. The arrows indicate the transcriptional start site. 
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Figure 2. Results of CAT assays (mean of four independent assays ± SEIVI), 
using the multiple immunoglobulin promoter constructs in the two chicken 
lymphocyte cell lines, (a) Results of using the germ-line promoter construct, 
with or without, the SV40 enhancer in a B-cell line (DT40) and a T-cell line 
(MSB1). (b) Results of mutating the octamer motif in the immunoglobulin 
promoter, with or without the SV40 enhancer, in a chicken B-cell line (DT40) and 
a T-cell line (MSB1). 
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CHAPTER 6. GENERAL CONCLUSIONS 
The immune system is an individual's defense against invasion from deleterious 
agents. As in any war, there are multiple methods for invasion that must all be 
defended. In defending an individual from invasion, the immune system employs 
many diverse mechanisms to prevent harm to the individual. Therefore, control of 
these multiple mechanisms is important in understanding immune function. Through 
understanding the control mechanisms of the immune system, immune modulation 
may become possible. Immune modulation would allow for increased health and 
welfare. 
The humoral immune response is a complicated system. The major product of 
the humoral response, immunoglobulins, are important in many instances including 
bacterial infections and parasitic infections. Regulation of immunoglobulin gene 
expression is not yet well understood. An understanding of immunoglobulin gene 
expression may provide alternative methods for both controlling and treating 
disease, ultimately providing increased animal health and welfare. 
Immunoglobulins, because they are expressed only in B-cells, also provide a good 
model for the study of tissue-specific expression of genes. 
In this study, we examined immunoglobulin gene expression using two 
approaches. One approach focused on examining the POU family of genes, a 
specific member of which encodes the protein Oct-2, hypothesized to be important 
in immunoglobulin gene expression in mammals. The second approach examined 
the functionality of the promoter region of the lambda light chain immunoglobulin 
gene and more specifically, the octamer motif located in the promoter. 
POU genes have been identified in many species, generally with a high level of 
homology between species. This was also true in the case of Oct-1 between the 
chicken and mammals. In the attempt to identify chicken Oct-Z, two new chicken 
POU genes were identified (Chapter 3). One of these, Bm-3a showed strikingly 
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high homology to human Bm-3a, suggesting a possible importance for this highly 
conserved gene. Another gene closely related to Oct-2, Skn-I/Oct-H/Epoc-I was 
also identified. Again, this gene showed relatively high sequence homology to its 
mammalian counterpart. Furthenmore, the Skn-1/Oct-11Epoc-1 gene identified a 
syntenic group in the chicken with human and mouse. The conserved homology of 
the two newly identified POU domain genes in the chicken supports the importance 
of this domain and family of genes. It also suggests that these genes may play a 
transcriptional regulatory role in the chicken as is seen in other species because of 
the conservation of the cmcial DNA binding domain. Bm-3a and Epoc-1/Skn-1/Oct-
11 genes were mapped to separate linkage groups with the identification of a 
chicken syntenic group conserved with mouse and human. 
Research evidence suggests that there may not be an Oct-2 gene in the 
chicken. Genomic and cDNA library screens and RT-PCR resulted only in clones 
from other POU genes, as did RT-PCR. Furthennore, EMSA results demonstrated 
the lack of a band at the precise location of the Oct-2 band seen in other species 
(Chapter 4). Taken together, these results suggest either the absence of a chicken 
Oct-2 gene or a chicken Oct-2 homologue with less conservation of sequence then 
has been previously described for POU genes across species. This would imply 
that immunoglobulin gene regulation may be different between the chicken and 
other species. Additionally, this may provide insight into the evolution of the POU 
gene family and its function in tissue-specific versus general transcriptional 
regulation of gene expression. 
The results of the electrophoretic mobility shift assay (EMSA) demonstrate the 
binding of chicken proteins to the octamer motif. The octamer motif is found in 
some transcriptional regulatory sequences (promoters and enhancers). Three 
different octamer oligonucleotides were used in which the octamer sequence was 
identical but the flanking sequences were different. We were unable to detect any 
differences in banding pattern among any of these oligonucleotides. Petryniak and 
coworkers (1991) found no differences in EMSA banding patterns between the full 
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immunoglobulin lambda light chain promoter and the shortened oligonucleotide 
used in their research. This suggests that binding reflects binding only at the 
octamer site and not in regions of the flanking sequence. However, it is possible 
that there are interactions also important to transcriptional activation via the octamer 
site that require other interactions not being detected by using these 
oligonucleotides. These interactions could include protein-protein interactions with 
octamer-binding proteins that require specific flanking sequences. 
The EMSA results identified differences in tissue-expression pattems for 
chicken octamer-binding proteins. Specificity of DNA-binding was shown by using 
mutated binding sites in the octamer motif in competition assays. It appears that 
there are at least seven octamer-binding proteins in the chicken. Many of these 
proteins are expressed in multiple tissues, with the exception of one liver protein 
which is expressed only in liver. Only one band, identified as Oct-1, is ubiquitously 
expressed. It cannot be determined from this assay whether these binding reactions 
(bands) represent products of separate genes or distinct proteins created from the 
same gene (alternative splicing). 
Comparison of octamer-binding pattems in the chicken to that of mammals 
shows both similarities and differences. Most noteworthy is the absence of a band 
in any of the chicken tissues at the same position in which Oct-2 appears in mouse 
and human extracts. This suggests that if an Oct-2 homologue exists in the 
chicken, it may be a different size than in mice. Interestingly, the POU genes 
identified thus far in the chicken share striking homology to their mammalian 
counterparts. Supershift assays, using a-Oct-1 antibody verified the designation of 
the slowest migrating band as Oct-1. 
Additional differences exist in the octamer-binding pattems between chicken 
and mouse. In the chicken tissues assayed in this study, there were a total of seven 
different octamer-binding proteins. The liver has a protein-octamer complex greater 
in size than the Oct-1 complex and also one lower in size, which is seen in ail 
tissues but not in the lymphoid cell lines. This is in contrast to mouse, where only 
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Oct-1 protein was detected in the liver (Scholer, 1991). There is a band in chicken 
tissues that displays slightly faster mobility than mammalian Oct-2. This band is 
found in multiple tissues and may represent a different and possibly chicken-specific 
octamer-binding protein. 
The EMSA research demonstrated the ubiquitous expression pattern of Oct-1 in 
the chicken as well as the existence of multiple tissue-restricted octamer-binding 
proteins. This shows that not only is the Oct-1 protein sequence highly homologous 
(Petryniak et ai, 1991) to mammals, but the expression pattem is also very similar, 
if not identical, as well. We identified the existence of octamer-binding protein with 
a migration pattem different to any seen in the mouse. Additionally, we were able 
to establish the existence of tissue-specific octamer DNA binding pattems for the 
chicken. Finally, it appears that Oct-2 , if existing in the chicken, may not be as 
homologous to the mouse protein as would be predicted by the identification of 
other POU proteins in the chicken. 
Though the immunoglobulin gene rean^angement mechanism is different 
between mammals and chickens, it appears that control of immunoglobulin gene 
expression may be very similar. Research focusing on the immunoglobulin lambda 
light chain gene has demonstrated that the promoter sequence is capable of driving 
CAT gene expression in concert with an enhancer sequence only in B-cells. An 
enhancer sequence must be present but does not need to be the immunoglobulin 
lambda light chain gene enhancer (non-specificity of enhancer interactions). The 
octamer motif is an important component of the chicken immunoglobulin lambda 
light chain promoter segment as was demonstrated by the mutation of the octamer 
motif sequence. Mutation resulted in complete inactivity of the construct that was 
active prior to mutation. This mutation, ATTTGCAT to ATATTCAT, also 
demonstrates the importance of these two bases, mutated base pairs, to binding 
activity. It remains to be determined if the promoter activity demonstrated here will 
also be seen with the chicken immunoglobulin heavy chain promoter. 
Future areas of research could include further characterization of the identified 
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POL) genes, Bm-3a and Epoc-1/Skn-1/Oct-11. The DNA-binding domain of the 
newly Identified POU genes remains highly conserved yet it is unclear if the 
remainder of the gene remains conserved. By isolating cDNA clones of the two 
genes, It would then be possible to examine full length homology of the gene. It 
would also be possible to use these cDNA clones in experiments examining DNA-
protein interactions to determine possible roles for these genes in the chicken. 
Finally, it might be good to retum to the original genomic clones isolated from the 
chicken genomic library to identify more POU domain genes. 
Further characterization of the immunoglobulin promoter would be useful in 
understanding the regulation of immunoglobulin gene expression. Deletion 
constructs might provide insight into the tissue-specificity of immunoglobulin gene 
expression as well as identify sequences, besides the octamer motif, important in 
transcriptional regulation. 
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APPENDIX A. SOUTHERN BLOT ANALYSIS OF PORCINE 
OCT-2 AND AVIAN OCT-1 
Introduction 
The Oct-2 gene has been isolated in many species including the pig. Southern 
blot analysis of porcine DNA identified a polymorphic band using the porcine Oct-2 
(Tuggle, Helm and Rothschild, 1994) cDNA as a probe. From this information, a 
Southem blot experiment using both avian and porcine genomic DNA to determine if 
there is evidence that the Oct-2 gene exists in the chicken. The porcine DNA was 
used as a positive control for Ocf-2.The porcine Oct-2 banding patterns had 
previously been established. The probes used included three pig Oct-2 probes (5' 
and 3' specific and full length Oct-2) and two chicken Oct-1 (5' and 3') probes. One 
additional probe used was a A/col restriction fragment from a chicken genomic clone 
believed to contain an Oct-2-like insert. It has now been established that this clone 
is chicken Epoc-1/Skn-1/Oct-11 (Chapter 3). 
Material and Methods 
DNA 
Chicken DNA was isolated from GH(13,13) and GHs(13,13) inbred white leghorn 
chickens. Porcine DNA came from two Durocs (D1663[X]: D6066[X]) and two 
Hampshires (H346[B]; H1756[B]) and was provided by Dr. M. Rothschild (Iowa State 
University, Ames, lA). The DNA was digested with Taq\ (Gibco, BRL) and H/ndlll 
(Promega, Madison, Wl) according to the manufacturer's instructions. 
Southern Blot 
Digested DNA samples were electrophoresed through 0.8% agarose gel at 42 
volts for 18 hours. The DNA was vacuum transferred to a N+ Nylon membranes 
(Amersham.Ariington Heights, IL). Two duplicate membranes were produced. The 
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membranes were individually probed with each of the ^^P-labelled DNA probes at 
65° C, ovemight. Multiple wash conditions were used on different occasions on the 
same membrane with the same probe but with separate hybridizations. These 
included IX SSC, 0.1% SDS at 65° C; 0.5X SSC, 0.1% SDS at 65° C; and 0.1X 
SSC, 0.1% SDS at 65° C. 
Results 
Tables 1 and 2 list the results from all of the labeling. The shaded lane titled "# 
Bands" lists the total number of bands identified with each probe in each digest. 
The next columns list the number of overlapping bands between the other probes. 
Most comparisons are of labeling on the same blot with the exception of the marked 
samples. 
Discussion 
The results demonstrate the possibility of the existence of an Oct-2-like gene in 
the chicken. The number of bands not homologous between Oct-1 and Oct-2 
probings suggests that some gene besides Oct-1, with high homology to 
mammalian Oct-2, exists in the chicken. Additionally, the band D probing suggested 
that the Clone 11 gene was not Oct-2. This result was affirmed when sequence 
analysis identified the gene in genomic clone 11 as Epoc-1/Skn-1/Oct-11. 
References 
Tuggle C.K., Helm, J. & Rothschild M.F. (1994) Cloning, sequence and restriction 
fragment length polymorphism analysis of a porcine cDNA for Oct-2. Animal 
Genetics 24, 141-145. 
Table 1. Chicken banding patterns identified by Southern blot analysis using multiple POU domain probes at a 
stringency of 0.5 X SSC, 0.1% SDS at 65° C. 
Skn-1/ 
RE # 
Bands 
pOct-
2 
5' pOct-2 3' pOct-2 5' cOct-1 3*cOct-1 Epoc 
pOct-2 HZ/idlli 1 - 0 1 0 0 0 
Taq\ 4 - 1 3 0 0 0 
5' pOct-2 H/ndlll 2 0 • 0 0 0 1 
Taq\ 7 1 - 2 0 0 
3' pOct-2 H/ndlll 1 1 0 - 0 1A 0 
Taq\ 3 3 1A - 0 1A 0 
5' cOct-1 H/ndlll 5 0 0 0 . 0 1 
Taq\ 5 0 2 0 - 1 0 
3'cOct-1 H/ndlll 4(5) 0 0 -JA 0 0 
Taq\ 4 0 0 r 1 - 0 
Skn-1/Epoc-1 H/ndlll 1 0 1 0 0 _ 
TaqI 0 0 0 0 - 0 -
^ Comparison of different blots (less accurate) 
The probes used were designated p for porcine and c for chicken. 
Table 2. Porcine banding patterns, identified by Southern blot analysis using multiple.POU domain probes at a 
stringency of 0.5 X SSC, 0.1% SDS at 65° C. 
RE Bands pOct-2 5' pOct-2 3' pOct-2 5' cOct-1 3'cOct-1 
Skn-1/ 
Epoc-1 
pOct-2 Hindm 6 - 0 1 3 0 0 
Taq\ 4(5) - 2 4 0 0 0 
5' pOct-2 Hind\\\ 5 0 - 1A 1 1 1 
Taq\ 5 2 - 0 0 0 0 
3' pOct-2 Hind\\\ 5 1 1A - 2A 0 1 
Taql 6(7) 4 0 - 0 r 0 
5' cOct-1 H/ndlll 7 1 2 2A 
Taq\ 3(4) 0 2 0 - 0 0 
3'cOcM H/ndlll 4 0 1 0 _ 1 
Taq\ 3 0 0 1A 0 - 0 
Skn-1/Epoc-1 H/ndlll 1 0 1 1 1 -
Taqfl 0 0 0 0 0 0 -
- Comparison of different blots - less accurate 
° - Faint bands as compared on film 
The probes used were designated p for porcine and c for chicken. 
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APPENDIX B. ISOLATION OF DNA CLONES 
INTRODUCTION 
The objective of this research was to first isolate an Oct-2 genomic clone followed by a 
cDNA done. This was to be done using both cDNA and genomic libraries. 
MATERIALS 
Human Oct-2 full length cDNA, Dr. LM. Staudt, NIH. 
Chicken Oct-1 cDNA's, Dr. C.B. Thompson, University of Chicago. 
Chicken Genomic Library, CLONTECH Laboratories, Inc. Cat. #: CL1012J 
Lot #: 3445. Adult Leg-horn Liver. EMBL3 SP6/T7. 
Chicken cDNA Library, CLONTECH Laboratories, Inc. Cat. #: CLIOISa 
Lot#: 6551. Spleen, 5' stretch. Lambda gtlO. 
FastTrack mRNA Isolation Kit, Invitrogen. Cat. #; K1593-02. 
Chicken Tissues - White leghorn GHs. 
pGEM-T Vector Systems, Promega, Cat. #: A3600. 
METHODS 
Genomic and cDNA Library Screens 
A. Plaque Lift Protocol 
1. Bacterial Culture Plating 
a. Streak 5 pi of the appropriate E. coli host strain from the glycerol stock 
culture on an LB agar plate. Incubate at 37°C ovemight. Store plate at 4°C. 
b. Pick a single, isolated colony and streak onto another LB agar 
plate. Be sure to check if the host strain being used requires any additional 
media additives (i.e. ampicillin). Incubate plate at 37°C ovemight. Store plate 
at 4°C. 
c. Pick a single isolated colony from the primary working plate and inoculate 
20 mis of LB broth + 0.2% maltose. Incubate on a shaker at 37°C ovemight 
and/or until the culture reaches an ODeoo of 2.0. 
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2. Titering/Plating 
a. Pipet 2 pi of phage lysate (or library) into 1 ml of IX Lambda dilution buffer 
(Dilution 1 -1:500) 
b. Transfer 2 mI  of Dilution 1 into a second tube containing 1 ml of IX 
Lambda dilution buffer (Dilution 2-1:250,000). 
c. Prepare 4 tubes as described in the following table, using the overnight 
culture obtained from step 3 above. 
Tube IX A. Dilution Buffer Bact. Culture Phage Dil. 2 
1 100 Ml 200 Ml 2 Ml 
2 100 Mi 200 Ml 5 Ml 
3 100 Ml 200 Mi 10 Ml 
_4 100 Ml 200 Ml Oj^  
d. Incubate tubes at 37°C for 15 minutes. 
e. Add 3 ml of melted LB soft top agar +10 mM MgS04 (45°C) to incubated 
tubes. 
f. Pour the contents from each tube in Step e onto 4 separate LB agar plates + 
10 mM MgS04. Swirl the plate carefully to allow for even spreading of the 
agarose. Note: If plates were prepared fresh and have been sitting at room 
temperature, prewarm plates at 37°C for 10 to 15 minutes. If plates have been 
previously stored at 4°C, prewarm plates at 37°C for 1 hour prior to use. Make 
sure the surface of the plate is free of liquid (liquid on the surface of the plate 
makes the plaques smear). 
g. Cool plates at room temperature for approximately 10 minutes. 
h. Incubate plates inverted at 37°C overnight. 
I. Count the plaques to determine titer (pfu/ml) 
pfu/ml = (# of plaques / Ml of sample used) x dilution factor x 10^ Ml/fr l^ 
3. Preparing Membranes for Screening 
a. Grow an overnight culture as done before (Bacterial Culture Plating). 
b. Prepare a sample of phage library diluted in 0.1 ml sterile IX X Dilution 
Buffer so that the phage library will yield a maximum of approximately 10,000 
pfu for each 90 mm plate (or approximately 30,000 pfu per 150 mm plate). 
c. Add 200 Ml of bacteria (ovemight culture) to library sample for 90 mm 
plates or 600 MI for 150 mm plates. Incubate at 37°C for 15 minutes. 
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d. Immediately add 3 ml (90 mm plates) or 7 ml (150 mm plates) of LB soft top 
agarose -t-10 mM MgS04 to the cell suspension. Mix and pour agarose on 
surface prewarmed LB plate. Swirl plate to evenly distribute agarose mixture 
over surface of plate. Be careful to not cause bubble formation both during the 
pouring and swiriing. Incubate at 37°C for 6 to 8 hours or until the plaques 
reach a diameter of 0.25 mm or until they are just beginning to make contact. 
Avoid confluent lysis. 
e. Chill plates for 1 hour to ovemight to harden top agarose. 
f. Prepare solutions for transfer Denaturing and Neutralization Solutions and 
3X SSC. Pour solutions into prelined (with Whatman paper) containers (either 
plastic or glass dishes). Note: Solutions will need to be changed during 
the transfer (i.e. after completing half the membranes replace buffers). 
Prepare another glass dish by lining it with Whatman paper wetted in 3X SSC. 
Finally line up containers in a row starting with denaturation solution, followed 
by neutralization solution, 3X SSC and finally the glass dish with Whatman 
paper. 
g. Number Nitrocellulose (Nylon) membranes remembering that two 
membranes will be used per plate (replicates), i.e. 1A, IB, 2A, 2B, .... 
h. Mark 3 asymmetrical dots on the bottom of each plate with a marking pen 
and then label plates. Place the filter (Schleicher & Schuell, nitrocellulose, 137 
mm (150 mm plates), 0.45 |jm) carefully onto the top agarose. Start from the 
middle holding the two outside edges up and then slowly release to the outside 
being careful to not introduce bubbles on the surface. Stab through the filter 
and agarose with a 20-gauge needle at the mari<ed locations. Leave the first 
filter on for 1 minute and the second filter for 3 minutes. (Note: DNA is on 
unmarked side.) 
i. Using forceps (be careful not to tear filter), peel off the filter and float it, 
plaque (DNA) side up, in denaturing solution (1.5 M NaCI, 0.5 M NaOH) for 30 
seconds, then submerge membrane and let stand for 60 seconds. 
j. Remove filter from denaturing solution, remove excess fluid on edge of tray, 
and place in neutralization solution (1.5 M NaCI, 0.5 M Tris) for 5 minutes. 
k. Remove filter and place in 3X SSC for 1 minute. 
I. Remove filter to glass baking dish lined with Whatman paper. 
m. Fix DNA to the filter using the UV Stratalinker (autoset), or other methods 
as recommended by manufacturer (I have had good success with Stratalinker). 
n. Partially dry filters in Whatman paper, do not allow to dry completely. 
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store in ziplock bag at 4°C. 
4. Labeling / Hybridization 
Because there are long prewash and prehybridization (prehyb) steps, it is 
necessary to start these very early. This procedure is for 20 to 24 137 mm 
nitrocellulose membranes. 
a. Label probe using standard laboratory protocols but filter (i.e. BioRad Spin 
Columns) to remove unincorporated nucleotides. You want approximately 1 
million counts per ml of hybridization solution. 
b. Set up prewash as follows. Put nitrocellulose membranes in random order 
in a 4 quart plastic container. Add 100 to 150 mis of prewash solution and 
incubate at 65°C for 1 to 1.5 hours on a shaker. Repeat once. 
c. Remove prewash. 
d. Add 100 to 150 mis of prehyb solution (use 0.038 to 0.05 mis prehyb 
solution per cm^ area of filter) and incubate at 37°C for 4 hours. Be sure to 
change the order of filters at least once. 
e. Near the end of prehybridization, boil probe(s) for 5 minutes. 
f. Pour off prehyb solution and place membranes on lid of container. Add 
hybridization solution (same as prehyb) to bottom of 4 qt container and add 
probe to solution. Finally, place membranes in hyb solution, put lid back, 
incubate on shaker at 37°C for approximately 18 hours. 
5. Washes/Films 
a. Wash membranes twice with 2X SSC, 0.1% SDS at room temperature, 5 
minutes per wash. This wash is done in 4 qt container. 
b. Transfer filters to large plastic container (7.8 L capacity). 
c. Wash 2 to 3 times with 1 L of 2X SSC, 0.1% SDS at 37°C (low stringency) 
or 1 L of 0.2X SSC, 0.1% SDS at 65°C (high stringency). 15 minutes per wash 
with shaking. 
d. Wrap membranes in plastic wrap, place in cassette (may help to add light 
emitting strips to use for lining up film after developing - Stratagene), add film. 
This can be done 2 membranes per small cassette (8x10) or 6 membranes per 
large cassette. 
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6. Analyzing Results 
a. Once the film is developed, match up film with membranes (must be exactly 
matched up) and mark on film the location of the needle holes from membrane. 
b. Then cut up film so replicate film from each plate can be matched via 
needle holes. 
c. Compare both films looking for positives that show up on both films 
(replicated). Mark positives on film. 
d. Next take film and match up needle holes marked on film with holes 
punched in agarose (be sure the film and plate are oriented property). 
e. Mark positives on bottom of agar plate(s). 
f. For primary screen use wide end of Pasteur pipet (opposite end) to remove 
plug containing positives. For secondary and tertiary screens, use nan-ow end 
of pipet. 
g. Place plug in 1 ml of IX A. dilution buffer and then add 1 to 2 drops of 
chloroform to lyse E. coli. Incubate overnight at 4''C. 
h. These samples if from primary screen can then be titered and used for 
subsequent screenings. If these sample(s) are from the last screen, they can 
be used to inoculate cultures for lambda DMA isolation. 
7. Buffers 
Denaturation Solution 
1 L 4L 
Neutralization Solution 
1L 4L 
I.SMNaCI 87.66 g 350.64 g 
0.5 M NaOH 20.00 g 80.00 g 
1.5MNaCL 87.7 g 350.8 g 
0.5 M Tris 60.0 g 242.4 g 
50X Denhardt's Solution Prewash Solution 
FIcoll 5 g 10X Denhardt's 60 ml (SOX Denhardt's) 
5 g 5X SSC 75 ml (20X SSC) 
5 g 0.1 % SDS 3 ml (10% SDS) 
Polyvinylpyrrolidone 
BSA 
Add ddHaO to 500 ml 
Filter, aliquot and 
store at 20°C 
0.1% NaPOP 3 ml (10% NaPOP) 
Fill to 300 ml with ddHaO 
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Prehyb Solution 
100 ml 300 ml 400 ml 
43% Formamide 29 ml 86 ml 115 ml 
5XSSG 17 ml 50 ml 67 ml (20XSSC) 
10X Denhardt's 13 ml 40 ml 53 ml (50X Denhardt's) 
0.1% SDS 700 pi 2 ml 1.7 ml (10% SDS) 
0.1% NaPOP 700 pi 2 ml 1.7 ml-(10% NaPOP) 
100 pg/ml Salmon Spenn DMA (boil 5 minutes before adding) 
B. PCR-based Library Screen 
1. Amplification of Phage 
a. Phage and bacteria (overnight culture) are incubated together in 1 ml of LB 
broth + 1X Lambda dilution buffer (1:1) at room temperature for 20 minutes 
(Note; Average Insert size of 20,000 bp, PGR amplification of 30,000 phage 
represents analysis of 6x10® bp) 
b. Dilute culture with 20 ml LB broth + 10 mM MgS04 
c. Plate 100 pi per well in an 8x8 matrix (96 well plate Costar) 
d. Seal plate with parafilm (prevents drying) 
e.. Incubate at 37°C for 5 to 6 hours shaking at 225 rpm 
2. Pooling Phage 
a. Pool samples by adding 25 pi from each well across and down (16 final 
samples) 
b. Dilute pooled samples 1:1 with ddHaO 
c. Seal plate with parafilm and store at 4°C. 
3. PGR Reactions 
a. Program (Libscr) Reaction Mix 
94° 1 minute 
55° 1 minute 
72° 2 minutes 
34 more times 
72° 7 minutes 
Stay at 4° 
50 pmoles of each primer 1 pi 
0.25 pi Taq (Promega 5000 U/ml) 0.25 pi 
200 pM each dinucleotide(1.25 mM) 4 pi 
2.5 mM MgGIa (25mM) 2.5 pi 
IX PGR Buffer(IOX) 2.5 pi 
0.5 pi template (Diluted pooled sample) 
Fill to 25 pi with ddHaO 
b. Run 1.4 to 2% gels 
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c. Transfer as usual 
d. Hybridize as usual (standard lab. protocol) but at 55°C 
e. Wash as normal but at 55° C with 5X SSC, 0.1 % SDS 
Lambda DNA Isolation 
A. Purification by Ammonium Sulfate 
1. Plate Lysate Preparation 
a. Prepare plates (90 mm)(with appropriate media for strain of bacteria) with 
approximately 1x10® plaque-forming units [Clear plates (total lysis) - better levels 
of lambda DNA following isolation] 
b. Incubate ovemight at 37® C 
c. Add 5 ml of lambda dilution buffer to each plate 
d. Slowly shake for 2 hours at room temperature 
e. Remove supernatant and clear by centrifugation (20,000xg) for 5 min at 4? C 
2. Purification 
a. Add an equal volume (5 mL) of super-saturated ammonium sulfate solution 
(4''C) to supernatant (step 5 above) and incubate on ice for a half hour. 
b. Centrifuge (20,000xg) for 20 min. at 4''C 
c. Decant supernatant 
d. Resuspend pellet in 0.5 mL of TE-SDS Buffer and transfer to microcentrifuge 
tube. 
e. Incubate with RNase A(20 mg/ml, use 2 pL) for 15 minutes at room 
temperature. 
f. Incubate with Proteinase K (200 mg/ml, ise 5 pL) for 20 minutes at eO'C. 
g. Place lysate on ice for 5 minutes. 
h. Gently mix 1/10 volumes of 1 M NaOH (O'C) and incubate on ice for 10 min. 
i. Add 200 pL of 10 M ammonium acetate. 
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j. Centrifuge (16,000xg) for 10 minutes at 4''C. 
k. Remove supematant and split eacin sample into tywo tui3es (approx. 500 pL). 
I. Add an equal volume of Phenol (500 pL of phenol), gently mix, and centrifuge 
(16,000xg) for 10 minutes 
m. Add an equal volume of Phenol/Chloroform, gently mix and centrifuge (same 
as above) for 3 minutes. 
n. Repeat if necessary (Remove protein until interface is clear) 
o. Add an equal volume of Chlorofonn, gently mix, and centrifuge 9 same as 
above) or 3 minutes. 
p. To supematant add an equal volume of ice cold 2-propanol and incubate 
overnight at -ZCC (Originally it was only 2 hours but overnight worked much 
better). 
q. Centrifuge (16,000xg) for 20 minutes at 4''C. 
r. Rinse pellet twice with 70% Ice cold EtOH (approximately 500 pL) 
s. Dry pellet under vacuum. 
t. Resuspend pellet in 20 ml of 10 mM Tris-HCI. 
u. [Optional] Incubate at 65°C for 10 minutes (To dissolve pellet). 
Autoclave. Store at 4°C 
TE-SDS Buffer 
10 mM Tris-HCI 
5 mM EDTA 
0.1% SDS 
B. Large Scale Lambda Isolation 
1. Liquid Lysate Preparation 
3. Buffers 
10X Lambda Dilution Buffer 
1.0 M NaCI 
0.1 M MgS04 7H20 
0.35 M Tris-HCI (pH 7.5) 
IX Lambda Dilution Buffer 
100 ml 10X Lambda Dilution Buffer 
5 ml 2% gelatin 
Add water for 1 liter volume. 
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a. Inoculate 100 mL NZCYM in 500 mL flask with single colony -> Incubate 
overnight at 37° C with agitation 
b. ReadODsoo (1 OD6oo=8x10® cells/mL) 
2. Bacteriophage Preparation 
a. Withdraw 2 aliquots, each with 1x10"° cells. Centrifuge at 4000xg for 10 
minutes to pellet cells. (# of aliquots depends on # of samples) 
b. Resuspend each pellet in 3 mL SM. 
c. Add 5x10' to 5x10® phage particles in 100 mL SM add to bacteria 
resuspended in SM and mix rapidly. 
d. Incubate at 37° C for 20 minutes with intermittent shaking. 
e. Add each aliquot to 500 mL NZCYM prewarmed to 37° C in 2 L flasks -
>incubate at 37° overnight (check for lysis before stopping)[lysis at 
approximately 12 hours] 
f. Add 10 mL chloroform, incubate at 37° C for 10 minutes. 
g. Cool lysed cultures to room temperature and add DNasel (50 mL of 10 
mg/mL) and RNase (50 mL of 10 mg/mL) each to final concentration of 1 mg/mL 
Incubate for 30 minutes at room temperature. 
h. Add solid NaCI (29.2 g/500 mL culture) -> dissolve by swiriing -> Cool on ice 
fori hour. 
i. Centrifuge at 11.OOOxg for 10 minutes at 4° C to remove debris. Pool 
supematants in clean flask. 
]. Add PEG 8000 to final concentration of 10% w/v (50 g/500 mL) and dissolve 
by slow stimng on magnetic plate at room temperature. 
k. Cool in ice water -> let stand on ice for 1 hour to allow precipitation of lambda 
particles. 
I. Centrifuge at 11,000xg for 10 minutes at 4° C -> discard supernatant and tilt 
bottle to allow fluid to drain away from pellet (Remove fluid with pipette). 
m. Gently resuspend with wide-bore pipette in SM (8 mL for every 500 mL 
original culture). Transfer to Corex tube. 
n. Chloroform-extract (PEG and debris) with equal volume of chlorofonn. Vortex 
for 30 seconds twice (Cover with parafilm and hand). Centrifuge at 3000xg for 
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15 minutes at 4° C. Recover aqueous phase. 
0. Measure volume and add 0.75 g CsCI/mL suspension. Mix to dissolve. 
Transfer to ultracentrifuge tube that fits Ti50 or SW50.1 rotor. Rll tube with SM 
containing 0.75 g CsCI/mL. 
p. Centrifuge at 38,000 rpm for 19-24 hours at 15° C (CsCI may come out of 
solution at lower temps). 
3. DMA Isolation 
a. Remove CsCI by dialysis against buffer 
10 mM NaCI (2 mL of 5 M NaCI / L of dialysis buffer) 
50 mM Tris, pH 8 (50 mL of 1 M Tris / L of dialysis buffer) 
10 mM MgC^ (10 mL of 1 M MgC^ / L of dialysis buffer) 
for 1 hour at room temperature, change buffer and repeat. 
b. Transfer suspension to plastic tube (500 |JL in 1.5 mL centrifuge tube). Add 
EDTA from a 0.5 M stock (pH8) to final concentration of 20 mM (40 mL/mL). 
c. Add proteinase K to final concentration of 0.5 mg/mL (1.25 tJL of 20 mg/mL 
in 500 pL). 
d. Add SDS to final concentration of 0.5% and mix (13 JJL of 20% soln in 500 
pL) 
e. Incubate at 56° C for 1 hour. 
f. Cool to room temp, and add an equal voUme of phenol. Mix. Centrifuge at 
3000xg for 5 minutes at room temperature. Transfer aqueous phase to clear 
tube. 
g. Extract with equal volume of phenol/chloroform, recover as above. 
h. Extract with chloroform, recover as above. 
1. Ethanol precipitate by adding 3M NaOAc (pH7) to final concentration of 0.3 M 
and add 2 volumes (fill up the tube) of 100% EtOH. Mix. Incubate for 10 
minutes on ice. 
j. Centrifuge for 5 minutes at 3000xg and aspirate off EtOH. 
k. Rinse pellet with 70% EtOH and recentrifuge. Dry pellet on speed vac. 
I. Redissolve each tube in 100 mL of TE. 
m. Determine concentration and dilute to approximately 500 mg/mL. 
117 
3. Buffers 
NZCYM Medium 
To 950 mi of deionized 1-^0 add: 
10 g NZ Amine 
5g NaCI 
5g Bacto-yeast extracts 
1 g Casamino acids 
2 g IVIgS04 THjO 
Sliake until the solutes have dissolved. 
Adjust the pH to 7.0 with 5 N NaOH (-0.2 ml) 
Adjust the volume of the solution to 1 L. with 
deionized HaO. Sterilize by autoclaving for 20 
minutes. 
RT-PCR for cDNA Identification 
A. mRNA Isolation 
1. Preparation of Cell Grown in Tissue Culture (Invitrogen Kit) 
a. Wash cells in 4° C phosphate buffered saline(PBS) and transfer into a 50 
ml centrifuge tube (3x10® cells, maximum). Pellet cells and continue with 
procedure or store at -70 ° C. 
b. Resuspend and lyse cells in 15 ml of FastTrack lysis buffer. 
2. Preparation of Tissue 
a. Excise tissue and immediately freeze in liquid nitrogen (1 g, maximum). 
b. Cut tissue into 0.5 cm cubes while tissue is still frozen. 
c. Grind tissue with mortar and pestle under liquid nitrogen. 
d. Pour suspension of tissue and liquid nitrogen into a 50 ml tube and allow 
liquid nitrogen to evaporate. 
e. Add 15 ml FastTrack lysis buffer. 
3. mRNA Isolation 
a. Pour lysate into a sterile 50 ml Dounce homogenizer at RT. Homogenize 
with 10 to 12 up and down strokes, or until the viscosity resembles that of 
the FastTrack lysis buffer. 
SM 
Per liter 
50 mM Tris-HCI, pH 7.5 
100 mM NaCI 
8 mM MgS04 
0.1% gelatin 
Sterilize by autoclaving. 
Store in 50 ml Aliquots. 
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b. Pass the lysate through a 18-21 guage needle 2 to 4 times. 
c. Incubate at 45° C for 15 to 60 minutes (longer times for tissue). If soluble 
material is still evident, spin at 4,000 x g for 5 minutes and transfer the 
supematant to a new tube. 
d. Adjust the NaCI concentration of the lysate to 0.5M with the 5M NaCI 
solution (0.95 ml of 5M NaCI for each 15 ml of lysate buffer which is 0.2 M 
NaCI to start). 
e. Add one Oligo (dT) Cellulose tablet to the lysate. Seal the tube, allow the 
tablet to swell for 2 minutes, and rock gently by hand until the tablet disperses. 
Rock the tube gently at RT for 15 to 60 minutes. 
f. Pellet the Oligo (dT) Cellulose at RT at 2,000-4,000 x g in table top or 
similar centrifuge (4 to 8 minutes). 
g. Aspirate the supematant, resuspend Oligo (dT) Cellulose in 20 mis of 
binding buffer. 
h. Pellet as in step f. 
I. Resuspend in 10 ml binding buffer. 
j. Repeat step f. 
k. Resuspend in 10 ml of Low Salt Wash Buffer. 
I. Repeat steps ] and k until the buffer is no longer cloudy. Resuspend the 
Oligo (dT) Cellulose in Low Salt Wash Buffer at a final volume not to excede 
0.8 ml. 
m. Pipet sample into spin column. Spin at RT for 10 sec. at 2,000-5,000 x g. 
Remove column from microfuge tube and discard liquid inside the microfuge 
tube. Repeat this process as many times as necessary to transfer the 
cellulose to the spin column. 
n. To wash, place column back into tube, fill to top with Low Salt Wash Buffer 
and respin for 10 seconds, repeat wash at least three times or until the 
OD260 of the "flow-through" is ^ 0.05. 
0. Place spin-column into new microcentrifuge tube. Add 200 pi of Elution 
buffer and mix buffer into cellulose bed with sterile pipet tip. spin for 10 
seconds, add a second 200 pi of Elution Buffer to column, mix cellulose, and 
respin. Remove column from tube. 
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p. Precipitate mRNA with 0.15 volume of 2M Sodium Acetate and 2.5 
volumes of 200 proof (100%) etiianol, freeze at -70° C until solid. Spin in 
microcentrifuge at maximum speed for 15 minutes and remove ethanol. 
Respin briefly and remove traces of ethanol. Resuspend RNA pellet in 20-50 
Ml elution buffer. 
B. Total RNA Preparation 
1. Protocol 
a. Pellet 1x10® cells in a 15 ml tissue culture tube (1x10®= 3 mg) 
b. Rinse pellet with PBS and repellet. 
c. Repeat step b. 
d. Add 100 |j| of solution D per 1x10® cells. 
e. Add in order (invert tube after addition); 
100 (Jl of 2 M Sodium Acetate pH 4.0 
1 ml phenol (water-saturated) 
200 [Jl chloroform-isoamyl alcohol mixture (49:1) 
f. Shake vigorously for 10 seconds. 
g. Incubate on ice for 15 minutes. 
h. Centrifuge for 20 minutes at 10,000 x g at 4°C. 
I. Transfer aqueous phase to fresh tube. 
j. Add 1 ml of isopropanol. 
k. Incubate for at least 1 hour at - 20°C. 
I. Centrifuge for 20 minutes at 10,000 x g at 4°C. 
m. Remove supernatant. 
n. Add 300 pi of Solution D. 
0. Transfer solution to 1.5 ml Eppendorf tube. 
p. Add 1 volume of isopropanol. 
q. Incubate for 1 hour at -20°C. 
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r. Spin in microcentrifuge (full speed) for 10 minutes at 4°C. 
s. Resuspend pellet in 75% EtOH. 
t. Repeat step r. 
u. Vacuum dry the pellet. 
V. Redissolve in 50 pi of DEPC-treated water (See Sambrook for instructions) 
or 50 Mlof0.5%SDS. 
w. Heat to 65°C for 10 minutes to resuspend. 
2. Buffers 
Solution D 
4 M Guanidinium thiocyanate 
25 mM sodium citrate pH 7 
0.5% Sarcosyl 
0.1 M 2-mercaptoethanol 
C. First Strand Synthesis 
1. Protocol for Synthesis 
a. Prepare RNA by heating tube for 5 minutes at 65°C, then place on ice. 
b. To a tube, add the following; 
20 |j| 5X RT Buffer (Promega) 
10 MlDTT(IOOmM) 
2 pi Random Primers 
58.5 Ml dNTP's (2.5 mM) 
0.5 |jl Rnasin (40 U/pl) 
9 |jl RNA Sample (~5 pg) 
c. Add 10 pi RT (AMV, 7.5 U/M1), mix 
d. Transfer 10 pi to separate tube, add 1 pi dCT^^P (10 pCi/pl). 
e. Incubate at RT for 5 minutes. 
f. Incubate at 37°C for 1.5 hours. 
g. Spot 1 pi of hot sample and check incorporation (TCA Precipitation). 
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2. Protocol for Purification of cDNA's 
a. Extract with 1 volume of Phenol. 
b. Transfer top layer to new tube. 
c. Add 100 Ml TE to phenol layer and reextract. 
d. Add top layer to previous layer. 
e. Extract with 1 volume of PhenoliChloroform. 
f. Extract with 1 volume of Chloroform. 
g. Add 1 pi of glycogen, 55 pi 9M NH4OAC. 
h. Add 2 volumes of EtOH. 
I. Incubate at -20°C for 15 minutes, 
j. Microfuge at 4°C for 10 minutes. 
k. Wash pellets with 1 ml of 70% EtOH. 
I. Microfuge for 3 minutes at 4°C. 
m. Dry pellet. 
n. Resuspend in TE (15-20 ng/pl). 
3. POU Degenerate Primer PGR (RT-PCR) 
PGR PROGRAM Reaction Mix 
1 4' 94°G 10X Buffer 5 Ml 
2 1' 94°G 1.25 mM dNTP's 8 Ml 
3 2' 51 °G Primer 1 1.5 Mg 
4 3' 72°G Primer 2 1.5 Mg 
5 Goto step 2 39 more times Taq Polymerase 2.5 U 
6 5' 72°G MgClz 2.5 mM 
7 4°C 
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Table 1 - Probes used for genomic library screening 
Probe Name Size Region Reference 
Chicken Oct-1 
5' 
3' 
986 
995 
947 
1283 
POU-specific 
POU-homeobox 
PNAS 87:1099-1103 (1990) 
Porcine Oct-2 
genomic 
cDNA 
5' Specific 
- 3' specific 
g15 850 
422 
635 
POU Domain 
POU Domain 
3' Flanking Region 
5' Flanking region 
Animal Genetics 25:141-145 (1994) 
Rat Pit-1 p226.3 1.5kb POU Domain 
Porcine Pit-1 44A 387 POU Domain Animal Genetics 24:17-21 (1994) 
Human Oct-2 P21 ~2kb Full Gene Cell 55:135-144(1988) 
Table 2. Results of secondary screening of genomic library 
Plate Label Mixed probe Oct-2 Probe % Oct-2 Positive 
gi 1 0 0 
g2 2 0 0 
g3 0 NO N/A 
g4 8 0 0 
95 6 3 50 
g6 0 ND N/A 
g7 4 0 0 
98 24 9 37.5 
g9 0 ND N/A 
gio 0 ND N/A 
gii 0 ND N/A 
gi2 0 ND N/A 
gi3 4 0 0 
gi4 5 4 80 
gi5 13 0 0 
gl6 6 2 33.3 
gi7 15 6 40 
gi8 0 ND N/A 
gi9 8 3 37.5 
g20 55 39 70.9 
921 45 23 51.1 
g22 0 ND N/A 
g23 27 11 40.7 
g24 23 19 82.6 
Totals 246 119 48.4 
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Table 3. Results of Southern blot with lambda DNA. 
Sample# Plate DNA Positives Sample # Plate DNA Positives 
1 g20B - 33 94 ND 
2 g20C - 34 94 ND 
3 g23 - 35 94 ND 
4 923 - 36 94 ND -
5 g24E + 37 g5 -
6 g24A ++ 38 g5 + 
7 g24B ++ 39 g5 + 
8 gl4A - 40 94 ND 
9 g20A - 41 94 ND 
10 g24C - 42 g8 + 
11 g24D ++ 50 g8 -
12 g8 + 51 g8 + 
13 g5 - 52 g8 -
14 g2 ND 53 g8 + 
15 g4 ND 54 g8 + 
16 95 + 55 g8 + 
17 97 ND 56 g8 -
18 gl9 - 57 g8 -
19 gi9 - 58 g8 -
20 g2lD - 59 g8 + 
21 g2lA - 60 g8 + 
22 g2lC - 61 g8 + 
23 gl6 - 62 g8 + 
24 gl6 - 63 g8 + 
25 g7 ND 64 g8 + 
26 97 ND 65 ND 
27 97 ND 66 97 ND 
28 97 ND 67 g21B -
29 g17 - 68 gi4 + 
30 gi7 - 69 g24 -
31 92 ND 70 g20D + 
32 94 ND 
+ Positive after 21 hours 
++ Positive after 4 hours 
ND Not Done 
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LOCUS GGU77642 350 bp mRNA VRT 24-NOV-1996 
DEFINITION Gallus gallus POU domain factor (Bm-3a) mRNA, partial cds. 
ACCESSION U77642 
NID g1684821 
KEYWORDS . 
SOURCE chicken. 
ORGANISM Gallus gallus 
Eukaryotae; mitochondrial eukaryotes; Metazoa; Chordata; 
Vertebrata; Archosauria; Aves; Neognathae; Galliformes; 
Phasianidae; Phasianinae; Gallus. 
REFERENCE 1 (bases 1 to 350) 
AUTHORS Heltemes.L.M., Tuggle.C.K. and Lament,S.J. 
TITLE Identification and mapping of two chicken POU family genes 
JOURNAL Unpublished 
REFERENCE 2 (bases 1 to 350) 
AUTHORS Heltemes,L.M., Tuggle,C.K. and Lamont,S.J. 
TITLE Direct Submission 
JOURNAL Submitted (07-NOV-1996) Animal Science, Iowa State University, 201 
Kildee Hall, Ames, lA 50011, USA 
FEATURES Location/Qualifiers 
source 1. .350 
/organism="Gallus gallus" 
/strain="White Leghom" 
/map="linkage group E48, East Lansing reference mapping 
population" 
/tissue_type="spleen" 
CDS <1..>350 
/gene="Bm-3a" 
/codon_start=2 
/product="POU domain factor" 
/db_xref="PID:g1684822" 
/translation="VTQADVGSALANLKIPGVGSLSQSTICRFESLTLSHNNMIALKP 
ILQAWLEEAEGAQREKMNKPELFNGGEKKRKRTSIAAPEKRSLEAYFAVQPRPSSEKI 
AAIAEKLDLKKNW" 
BASE COUNT 76 a 118 c 109 g 471 
ORIGIN 
U77642 Length: 350 March 17, 1997 11:49 Type: N Check: 5751 .. 
1 GGTGACCCAG GCCGACGTGG GCTCGGCGCT GGCCAACCTG AAGATCCCGG 
51 GCGTGGGCTC GCTCAGCCAG AGCACCATCT GCCGCTTCGA GTCGCTGACG 
101 CTGTCGCACA ACAACATGAT CGCCCTCAAG CCCATCCTGC AGGCCTGGCT 
151 GGAGGAGGCC GAGGGGGCCC AGCGGGAAAA AATGAACAAG CCCGAGCTCT 
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201 TCAACGGGGG CGAGAAGAAA CGCAAGCGGA CTTCCATCGC CGCCCCGGAG 
251 AAGCGCTCCC TGGAGGCGTA CTTCGCCGTC CAGCCCCGGC CCTCCTCCGA 
301 GAAGATCGCT GCCATCGCCG AGAAATTGGA CCTCAAAAAG AACGTGGTGC 
Figure 1. GenBank entry for chicken Bm-3a cDNA done. 
Figure 2. Amino acid alignment of chicken Bm-3a coding sequence with other Brn-3 proteins. Boxed in regions 
represent homologous amino acids. hBrn-3_ex2 - human Brn-3 exon 2; mBrn-3 - mouse Brn-3a; cBrn-3a -
chicken Brn-3a; cBrn-3Ji - chicken Brn-3 from liver; Oct-3/5 - mouse Oct-3 and 5. 
hBrn-3_ex2 OQVAAASAAAAVVOA AOLASICDSDTDPRB LBAPABRPKQRRZKL a|VTQADVaSAI.ANi:>K ZPOVOSLSOSTICRP BSLTLSHNNNIALKP 
inBrn-3 OQVAAASAAAAVVaA AOLASICDSDTDPRB LBAPABRPKQRRIKIi GVTQADVOSALANLK ZPaVOSLSQSTICRP BSLTLSHNNNIALKP 
cBrn-3a jvTQADVaSALANLK IpavOSLSQSTICRP BSLTLSHNNNIALKP 
cBrn-3 11 BTBTDPRB LBSPABRFKQRRIKL QiVTQADVaSALANLK IPGVaCLSQSTICRP BSLTLSHNNMVULKP 
Oct-3/5 BDTPTSDD LBQFAKQFKQRRIKL Q^QADVQ|ijMjgT|ljY Q NVpjsolTlriCRP C^KP NJ 
•>4 
VR 
Vil 
hBrn-3_ex2 ILQAHLBBABOAQRB KMNKPBLFNQQBKKR KRTSIAAPBKRSLBA YPAVQPRPSSBKIAA lABKLDLKKNV 
inBrn-3 ILQAMLBBABOAQRB KMNKPBLPNOaBKKR KRTSIAAPBKRSLBA YPAVQPRPSSBKIAA lABKLDLKKNV 
cBrn-3a ILQAHLBBABOAQRB KMNKPBLFNOOBKKR KRTSIAAPBKRSLBA YPAVQPRPSSBKIAA lABKLDLKKNVV 
cBrn-3_li IIi|B|AHLBBABb^QRB KMTKPB 
Oct-3/5 
L^HLBBAB^QR PBityTjsODKKR KRTSIAAPBKRSLBA YPAVQPRPSSBKIAA lABKLDLKKNVV II 
LMHWLBBADSSSOS PTSIDKIAAOORIK^  KRTSIIBVSV^ C^ B^IS HlF^ .Kcip^ 8|AQB|l[r8 ljA^ L|o|tjB}Kj^ V R 
tVM FCNQRQKQKRMKPSA 
LVH PCNQRQKQKRHKPSA 
VM PCNQRQKQKRHKPSA 
VH PCNRRQKBKRHTPPO 
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LOCUS GGU77715 2340 bp DNA VRT 12-JAN-1997 
DEFINITION Galius galius POU gene, partial cds. 
ACCESSION U77715 
NID 91772831 
KEYWORDS . 
SOURCE chicken. 
ORGANISM Galius galius 
Eukaryotae; mitochondrial eukaryotes; Metazoa; Chordata; 
Vertebrata; Archosauria; Aves; Neognathae; Galliformes; 
Phasianidae; Phasianinae; Galius. 
REFERENCE 1 (bases 1 to 2340) 
AUTHORS Heltemes.LM., Tuggle.C.K. and Lamont,S.J. 
TITLE Identification and mapping of two chicken POU family genes 
JOURNAL Unpublished 
REFERENCE 2 (bases 1 to 2340) 
AUTHORS Heltemes.LM., Tuggle,C.K. and Lamont,S.J. 
TITLE Direct Submission 
JOURNAL Submitted (07-NOV-1996) Animal Science, Iowa State University, 201 
Kildee Hall, Ames, lA 50011, USA 
FEATURES Location/Qualifiers 
source 1..2340 
/organism-'Gallus galius" 
/strain="White Leghorn" 
/map="linkage group E49, East Lansing reference mapping 
population" 
CDS join(<228..373,488..624,1622..>1801) 
/note="Skn-1/Epoc-1/Oct-11" 
/codon_start=2 
/product="POU" 
/db_xref="PlD:g1772832" 
/translation="QGDVGLAMGKLYGNDFSQTTISRFEALNLSFKNMCKLKPLLEKW 
LSDAESAPLDSSMSTPSSYPSVNEMFGRKRKKRTSIETNIRSTLEKRFQDNPKPSSEE 
ISLIAEQLSMEKEWRVWFCNRRQKEKRISCPMPSPIKSPIYNSRLVRCSGL" 
BASE COUNT 597 a 523 c 586 g 6341 
ORIGIN 
1 GAI 1 11 lAAG CAGAGGCGGA TGAAGCTGGG GTTCACACCA GGTGAGCAGT TCTTCTATAG 
61 ATCACTGGTG TCACTTCGGA TGGACACATC GGGTTGGGGG AGTTTGGGCA GAGGAATGGG 
121 TGGAGGAAGG GTGTATATGG ATGGAGGAAT GGCAGATACA ATGGTAGGTA TAGATTTGCT 
181 TTGGAATTGG AATATCTCTT TCCAAATGTG TTGTGTCTTG TTCCCTGACA GGGTGATGTT 
241 GGCCTTGCCA TGGGGAAGCT CTATGGCAAC GACTTCAGCC AGACTACCAT TTCCCGCTTC 
301 GAGGCTCTCA ACCTCAGCTT TAAGAACATG TGCAAGCTCA AACCTCTGCT GGAGAAGTGG 
129 
361 CTGAGTGATG CGGGTAGGTG ACGTTCCATG TGTTCATTCG CTTTACGAGG TGCCACGGTT 
421 CCCAGAAAGG AGCTGGAAATGAAAATAACTTGTGATCTTCAGTATCTCCC I I I I ICTCTT 
481 TCCACAGAAT CTGCTCCTTT GGATTCCTCC ATGAGCACTC CCAGCTCCTA CCCCTCCGTG 
541 AACGAGATGTTCGGACGGAA AAGGAAGAAG CGAACCAGCA TTGAGACCAA TATTCGCTCC 
601 ACGCTGGAGA AAAGATTCCA AGATGTGAGG AGAGAACGTT TCAATGTGTT GGGAGCTCTC 
661 CCACCATTTTTCTGTCTGTTTTGATAGCAG GCTAGGGGCG TGCTTGGGAA GATGCTTCCT 
721 TGCCCTGTTC TCTTTGGGAG CTGCTGGACA GCTCCTGTGG GTGCGGGAAG GAGCCAAGCA 
781 TTGCTACAGT GGGTGCTGCC CAACCATTCT GAAAGTGGAG ACTTTCACTT CTTAAACATG 
841 AAGGTTTTCA AGAAAAAATC ACTACAGAGA GTGAACAGAG CTTTCAGTCA GTTGGGGTAC 
901 ATCATCCATT GAACG I I I I I CATCAAAACT CTTTCTGGCC AGCCCTCGTT TTTCCTTGTT 
961 TTCTCCATCA CATCTGATCA TGTCAAATTT TCCTTCTATG GCTGTTGACG AGAACAAAAG 
1021 GCAGTCATTT TCAGATCTTT CCAGGCAGCT CAI I I I I lAG CGAGTACCTA TTCTTTGTAA 
1081 CAGGAAAGCT GCCCTGGCAT CACCATGCTG GGTTG I I I I I CCCCTGAAGT CTCCAACTCA 
1141 GATCAAAAAC CACCAACCTA ATGCTGTCAA GCGTGCCAGA AAATGAGTGA GTCAGAAAAA 
1201 AGAGGATGGG GTACATTTAT AAACAGGGGA TGGAGGAAGA AAGAGATGAA ATGGTTTTGT 
1261 GAGATGGTGC AGGGGTGTAC AACAGCACTC GGAGCTGTGT CCAATAGCCA TGACTTCCTC 
1321 TCCAGCGACT ACTGAGGGTG CTGCTGGGAT CAAAGCGTTG CATGCTTTGT GCAACAGCAG 
1381 GGCCAGGCAC TGTGACTCAT CCCCGCTGAT TCCATGGGAT CTGATGTTGA ATCAGAGGCG 
1441 CTTTTCTGGT TCACAGAACG TGATCTCTCA TACAAATGTT TACCTTTTGC CTTAGAAGCA 
1501 AATTTTCTGC CCTCTCCAGT TTACAACCCA CCCCACCCTT GTCCAGCAAC AGAAGAATGC 
1561 ACTGACGCCA TAAGTCAGAG ACATCTGGAG CCTTCTTTAA CCTCCTGCTA TTTCTTAGCA 
1621 GAACCCCAAG CCCAGCTCAG AGGAGATCTC CTTGATAGCA GAGCAGCTCT CCATGGAAAA 
1681 AGAAGTGGTT CGGGTCTGGT TCTGCAACCG GCGCCAGAAG GAAAAACGGA TCAGCTGCCC 
1741 GATGCCATCC CCCATCAAAT CGCCCATCTA CAATTCCAGA CTGGTGAGAT GCTCGGGGTT 
1801 GAGGAGCTGA ATTCCATCCA TGCAGAAATG CAGAATGCAC AGCAGTGGTG TTACCTGTCC 
1861 TTCTCACATA TTGCACGTTT CCATTTCGGC AAGGGTATTT TCATTCCCAA GAAAGACAGA 
130 
1921 AGAAATTGTG AGAGATAGTG GAAGCACGTC CTGTGATCTG CTGGGATGTA ACAAGTTGCT 
1981 ATGTGCATTT CTGCCAGTTA ATATTTGCCC AGGAGCTTCC ATGTATAAAA GTGGCAGGAA 
2041 CCTCCCTGTG GCGTCGGAAC TGGAGTGTAT GTGAGTAGGA GGGAGAGGAT GTATTCACAA 
2101 GCAGTATTTT ATCTTAAAAT CTTCTGGGTT TCAGAATTAT CTATTAGAAG GCAGAAAAAC 
2161 ATCCTGAGAA GTTTGGTCAC TTGTTGCACA ACACCTTTGG TCTACAGTTG CAAGCACAAG 
2221 ATGAATTCTT ACAGCAGCAG CTTTGGTGGA TGGTTATCCT GTGAATGCGT CATGCAGAGT 
2281 GCTCATCAGT CACTCTGACC AACACATTGT CTGTAGTTGA GGTATCTCAG TTGGACTCCA 
Figure 1. GenBank entry for chicken Skn-1/Epoc-1/Oct-11 genomic clone. 
Figure 4. Amino acid alignment of chicken Skn-1/Epoc-1/Oct-11 coding region with other POU class II proteins. 
Boxed in regions represent homologous amino acids. mEpod- mouse Epoc-I; rSknIa - rat Skn-1a; cSkn1 -
chicken Skn-1/Epoc-1/Oct-11; mOct11 - mouse Oct-11; cOct-1 - chicken Oct-1; hsoct2a - human Oct-2. 
mBpocl 
rsknla 
cSknl 
mOctll 
cOct-1 
hsoct2a 
POPaONDBPTDLBBL BKFAKTFKQRRIKLQ FTOjaDVOLAMOKLYQ MDPSQTTISRFBALN LSFKNMCKLKPLLBK HLND|P|B8SPSD 
PaPaOHDBPTDLBBlj BKFAKTFKQRRIKLQ FT CCQ' DVaiiAMOKLYQ NDF8QTTXSRFBALN liSFKHMCKLKPliLBK HliNDABSSP 
QDVaLAMaKLYQ NDFSQTTISRFBALM LSFKNMCKLKPLLBK Hl^ ABsiklE 
POPaONDBPTDLBBL BKFAKTFKQRRIKLQ FT 
DTPS-LBBPSDLBBL BQFAKTFKQRRIKLQ FT 
BPPSHPBBPSDLBBL BQFARTFKQRRIKLQ FT 
AD 
SAS 
SAS 
QQ 
QO 
QQ 
LDS£|M| 
DVaLAMOKLYQ NDFSQTTISRFBALM LSFKNMCKLKPLLBK NLNDABSSPSD^SAS 
DVQLAMQKLYQ NDFSQTTISRFBALN LSFKNMCKLKPLLBK MLNDAB^LSlSDS 
DVQLAMQKLYQ NDFSQTTISRFBALN LSFKNMCKLKPLLBK WLNDAB 
CO 
to 
mBpocl 
raknla 
cSknl 
mOctll 
cOct-1 
haoct2a S 
TPSSYPTLSBVFQ-- --RKRKKRTSIBTNI RLTLBKRFQDNPKPS SBBISMIABQLSNBK BVVRVHPCNRRQKBK RINCP 
TPSSYPTLSBVFQ-- --RKRKKRTSIBTNI RLTLBKRPQDNPKPS SBBISMIABQLSNBK BVVRVHPCNRRQKBK RINCP 
TPSSYPS^BMPO-- --RKRKKRTSIBTNI RLTLBKRPQDNPKPS SBBISQIABQLSHBK BVVRVHPCNRRQKBK RISCP 
TP8SYPTLSBVP0-- --RKRKKRTSIBTNI RLTLBKRPQDNPKPS SBBISMIABQLSNBK BVVRVHPCNRRQKBK RINCP 
P^LNSPOQOIBaV N-
^QLSSPSLOFDOL PC 
RRRKKRTSIBTNI R 
RRRKKRTSIBT N|V| RIFA 
LBK 
LBK 
PLBNQ KF 
LANQKI 
SBBI 
SBBl 
T^I 
L^ llABQt 
LNHBK BVIRVHPCNRRQKBK RIN PPSSaOTSSSPI 
HMBK BVIRVHPCNRRQKBK RIMlPC 
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APPENDIX C. EXPRESSION OF OCTAMER-BINDING PROTEINS 
INTRODUCTION 
The objective of this research was to examine the expression of patterns of octamer-
binding proteins. This was done using and electrophoretic mobility shift assay (EMSA). It 
included competitor assays and supershift assays using anti-human Oct-1 and Oct-2 
antibodies. 
MATERIALS 
Chicken tissues - White leghorn GHs. 
HeLaScribe Nuclear Extract, Gel Shift Assay Grade. Promega, Cat. #: E3521. 
Oct-1 Gel Shift Oligonucleotides. Santa Cruz Biotechnology Cat. #: sc-2506, mutant 
sc-2515. 
a-Oct-1. Santa Cruz Biotechnology Cat. #; sc-232. Rabbit polyclonal IgG. 
a-Oct-2. Santa Cruz Biotechnology Cat. #: sc-233. Rabbit polyclonal IgG. 
a-Oct-2. Dr. L. Staudt, NIH. 
METHODS 
Protein Extract Isolation 
A. Whole Cell Quick Preparation 
1. Procedure 
a. Reduce tissue to powder in liquid nitrogen using mortar and pestle 
All the following steps are earned out on ice!!!!!! 
b. In 15 ml dounce homogenizer the thawed powder is homogenized in 5 ml of 
solution A for 5 strokes. 
c. Transfer homogenate to 15 ml tube and centrifuge for 30 s at 2000 rpm 
(650xg). 
d. Incubate supernatant for 5 minutes on ice. 
e. Centrifuge for 5 min at 5000 rpm (4068XG). 
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f. Resuspend the nuclei in 100 to 500 pi of solution B (use as little as 
possible) 
g. Incubate on ice for 20 minutes. 
h. Transfer nuclei to microcentrifuge tube and centrifuge(16,000xg) for 15 
seconds. 
i. Aliquot samples and store at -70° C 
2. Buffers 
Solution A Solution B 
0.6 % Nonidet P-40 (NP-40) 25% glycerol 
150 mM NaCI 20 mM HEPES pH 7.9 
10 mM HEPESpH7.9 420 mM NaCI 
1 mM EDTA 1.2 mM MgCl2 
0.5 mM PMSF 0.2 mM EDTA 
(Phenylmethylsulfonyol fluoride) 0.5 mM DTT 
0.5 mM PMSF 
2 mM benzamidine 
5 ijg/Ml pepstatin, leupeptin 
and aprotinin 
B. Nuclear Extract / Whole Cell Extract Preparation 
1. Procedure 
a. Harvest cells (5 X 10^ to 1 x 10® cells) and centrifuge at 250xg for 10 
minutes. 
b. Wash with phosphate-buffered saline. Centrifugeat250xgfor 10 minutes. 
c. Resuspend in 5 volumes buffer A. 
d. Incubate on ice for 10 minutes. Centrifuge at 250xg for 10 minutes. 
e. Resuspend in 3 volumes buffer A. Add Nonidet P-40 to 0.05% and 
homogenize with 20 strokes of tight-fitting Dounce homogenizer to release 
nuclei. 
f. Centrifuge at 250xg for 10 minutes to pellet nuclei. 
g. Resuspend the pellet in 1 ml buffer C. Measure total volume and add 
NaCI to a final concentration of 300 mM. Mix well by inversion. 
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h. Incubate on ice for 30 minutes. 
i. Centrifuge at 24,000xg for 20 minutes at 4°C. 
j. Aliquot supernatant and freeze in liquid nitrogen. Store in -70°C fi^ eezer. 
Whole cell extracts are made by harvesting cells and washing. Resuspend 
1 ml of buffer C and homogenize with 20 strokes of a tight-fitting dounce 
homogenizer. Then add NaCI to a final concentration of 300 mM and 
continue from step h of the above protocol. 
Tough tissue may be pounded (broken up) using a mortar and pestle in the 
presence of liquid nitrogen. 
buffer C 
5 mM HEPES pH 7.9 
26% glycerol 
1.5 mM MgCIa 
0.3 mM EDTA 
0.5 mM DTT 
0.5 mM PMSF 
Nuclear Extract Protocol 
1. Protocol 
a. Add 4 ml of NE1 buffer to frozen tissue (1 to 2 g) 
b. Homogenize in 7 ml Dounce homogenizer -10 strokes 
c. Filter homogenate through 2 layers of cheese cloth 
d. Add Nonidet P-40® to a final concentration of 0.5% 
e. Homogenize for another 5 strokes as before 
2. Buffers 
PBS buffer A 
10 mM HEPES pH 7.9 
1.5 mM MgClz 
10 mM KCI 
0.5 mM DTT 
0.5 mM PMSF (Phenlymethylsulphonyl 
100 mM NaCI 
4.5 mM KCI 
7 mM NazHPO, 
3 mM KH2PO4 
Fluoride) 
f. Centrifuge for 8 minutes at 100 x g at 4°C 
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g. Discard supernatant 
h. Add 1 packed cell volume (PCV) of NE2 
i. Incubate for 5 minutes at 4°C 
]. Add1/10PCVof4MKCI 
k. Again homgenize as above - 20 strokes 
I. Transfer homogenate to 1.5 ml microcentrifuge tube and spin for 5 minutes 
at 12,000 xg at 4°C 
m. Transfer to ultracentrifuge tube and spin for 90 minutes at 180,000 x g 
n. Dialyze supernatant for 1 hour at 4°C against DNasel buffer 
0. Aliquot and freeze (Store at -70°C) 
2. Buffers 
NE1 
250 mM Sucrose 
15 mMTris-HCI, pH 7.9 
140 mM NaCL 
2 mM EDTA 
0.5 mM EGTA 
0.15 mM Spermine 
0.5 mM Spermidine 
1 mM DTT 
0.4 mM PMSF 
25 mM KCI 
2 mM MgCl2 
Electric Mobility Shift Assay 
A. Preparing gel apparatus 
1. Collect 2 glass plates (8'x8", 8'x7"), 2 side spacers (1 mm) with rubber 
pads, 1 bottom spacer (1 mm), 1 comb (1 mm) and 4 binder clips. 
2. Clean glass plates first with EtOH and then wipe clean with chloroform. 
3. Place cockstop grease along three sides of larger glass plate. 
NE2 
NE1 Buffer 
350 mM KCI 
DNasel 
50 mM KCI 
4 mM MgClj 
20 mM K3PO4 (pH 7.4) 
1 mM p-mercaptoethanol 
20 % glycerol 
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4. Place bottom spacer on and add additional grease to comers above 
bottonn spacer on glass plate. 
5. Add side spacers making sure there is no space left between bottom and 
side spacers at comers. 
6. Put cockstop grease on three sides of smaller glass plate.. 
7. Place smaller plate just below rubber pads of side spacers but up tight to 
pads with the ungreased edge matching the ungreased edge of lower glass 
plate. 
8. Before adding binder clips to secure plates, make sure there are no 
spaces between side and bottom spacers and rubber pads and top of plate. 
9. Place comb in at an angle and then rest clamped gel at about a 45° angle. 
10. Add acrylamide gel slowly down side until it reaches approximately the 
edge of the smaller glass plate. If bubbles appear, sometimes tapping the 
glass gently will help bring them to the surface. Additionally, it may help to 
move gel to a vertical position to remove bubbles. 
11. Place comb in proper position and allow gel to polymerize (Approximately 
20 minutes). Make sure comb is straight. 
12. After gel is polymerized, remove binder clips, bottom spacer and excess 
grease. To remove excess grease, run bottom spacer through between 
plates. Excess grease can interfere with electric current. 
13. Next, remove comb. 
14. Add 0.25X TBE running buffer to bottom reservoir of gel apparatus. 
15. Place gel vertically into gel box making sure no bubbles get trapped in area 
below gel. If you put gel in at an angle this can be avoided. Be sure the 
smaller plate faces inside and that rubber from side spacers match up with 
rubber pads on top reservoir. 
16. Clamp gel, with binder clips onto top reservoir. If only running one gel 
clamp one large plate to opposite side otherwise the top reservoir will not 
exist. 
17. Now add running buffer to top reservoir and connect power unit. 
18. Prerun gel at 150 V for approximately 1 hour to move salt front. 
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B. Running Gel 
1. Load samples with gel running (run at 150 V). Be sure to add gel loading 
buffer to one lane. 
2. Run gel until dye front gets about 1 to 2 inches from bottom. 
3. Remove some of the running buffer from top reservoir using a small 
beaker. 
4. Unclamp the gel from unit and lay on table. 
5. Gently pry plates apart leaving the gel on one plate. 
6. Remove gel from plate by adhering it to whatman paper. 
7. Dry gel to paper using vacuum dryer with heat. Place gel/whatman paper 
on extra piece of whatman paper and cover with saran wrap. Turn on heat 
and let go for 1 hour. 
8. Place dried gel in film cassette and expose to x-ray film 
C. Preparing Sample 
1. 1-5 pg Whole cell or nuclear extract from tissue of choice 
sample buffer (see buffer list at end of paper) 
2. 1 ijg of poly dl:dC per pg of extract 
3. Final volume should be 19 pi 
4. Then add 1 pi of labeled oligo (.1-.2 ng) and incubate at room temperature 
for 20 minutes. Note: for competition assay add 100 ng of competitor oligo 
prior to adding labeled oligo. 
D. Buffers 
5% ACRYLAMIDE GEL 
8.3 ml 30% acrylamide (29:1) 
1.25 ml 10XTBE 
0.5 ml 10% Ammonium Persulfate (fresh) 
39.95 ml ddHaO 
Add 35 pi of TEMED and mix well 
0.25X TBE Running Buffer 
50 mil OX TBE 
Fill to 2 L with ddHjO 
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Sample Reaction Buffer 
10 mM Tris 
50 mM NaCI 
1mM DTT 
1 mM EDTA 
5% glycerol 
Annealing Oligos 
1 pi 1 M NaCI 
1 |jl 100 mM Tris 
1 Ml 10 mM EDTA 
4 Mg of each oligo 
Fill to 10 pi, heat to 70°C for 5 minutes and 
add 1 |jg poly dIrdC. Cool to room 
temperature. Dephosphorylate See Below 
ends. 
Octamer Labeling 
200 ng oligo 
3 (Jl ddHjO 
4 Ml Y-labeled ATP f^ p) 
1 Ml 10X Blunt End Buffer (Clontech) 
1 m' T4 Polynucleotide Kinase (Clontech) 
Incubate 30 to 60 minutes at 37°C. 
Remove unincorporated nucleotides 
before using.(BioRad Spin Column) 
Dephosphorylate Oligos 
1 Ml Shrimp Alkaline Phosphatase 
50 Ml 10X Buffer 
-1-2 pmoles of ends 
Fill with ddHaO to 500 \i\ 
Incubate at 37°C for 2 hours 
Heat inactivate at 65°C for 15 min. 
Phenol/Chloroform extract, EtOH ppt. 
Resuspend in 25 mI TE and then dilute 
to concentration for labeling of 
competition assays 
EMSA Reaction Buffer 
(20 Mi reaction volume) 
80 Ml 1 M Tris pH 7.5 
80 Ml 5 M NaCI 
16 Ml .5 M DTT 
16 Ml -5 M EDTA 
400 Ml glycerol 
208 Ml ddHaO 
Western Blot 
A. Preparing gel apparatus 
1. Collect 2 glass plates (14 cm x 16 cm, 12 cm x 16 cm with ears), 3 spacers 
(1 mm), 1 comb, 4 medium binder clips and 2 large binder clips. 
2. Clean glass plate with chloroform. 
3. Place spacers on outside edges and bottom between plates and secure 
with binder clips (sides - 4 medium binder clips, bottom edge - 2 large binder 
clips). 
4. Seal spacers/edge of plates by running 2% agarose over edges with 
spacers (create seal). 
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5. Prepare 10% separating gel solution. 
6. Slowly fill between plates (~ 8 to 8.5 cm from the top of the short plate). 
7. Overlay gel with butanol. 
8. Allow gel to polymerize. 
9. Rinse off butanol water and dry with brown paper towel (slide between 
glass plates) 
10. Prepare 5% stacking gel. 
11. Pour gel and add comb. 
12. Allow to polymerize. 
13. Remove comb and bottom spacer. 
14. Secure gel to apparatus and fill upper and lower chambers with running 
buffer. 
B. Prepare samples 
1. Mix sample and 2X running buffer. 
2. Heat to 95° C for 5 minutes. 
3. Load samples. 
C. Running gel 
1. Run at 8 v/cm until dye front reaches separating gel. 
2. Run at 15 v/cm until dye front reaches bottom of gel. 
D. Coomassie Brilliant Blue staining the gel 
1. Incubate gel in stain for at least two hours, (check to be sure gel has 
turned blue) 
2. Destain in Destain solution changing the solution as needed (when blue 
change to new buffer) 
3. Dry gel on vacuum dryer 
E. Transfer protein to nitrocellulose 
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1. Cut 1 piece of nitrocellulose (and mark) and 4 pieces of Whatman 3 paper 
to the exact size of the gel. 
2. Soak gel, pads (from transfer apparatus), nitrocellulose and Whatman 
paper in transfer buffer. 
3. Lay plastic casing flat and then add in order (Be careful to remove all air 
bubbles): 1. Scour pad, 2. Whatman paper, 3. gel, 4. Nitrocellulose, 5. 
Whatman paper, 6. Scour pad. Close plastic casing. 
4. Put transfer chamber with gel closest to - electrode (cathode) 
5. Fill transfer tank with transfer buffer. 
6. Run at 200 mA for 5 hours. (Be careful to not overheat.) 
F. Labeling gel (ECL Amersham) 
1. Block membrane with Blocking Solution for at least 1 hr (overnight at 4° C) 
2. Wash membrane with TTBS. Rinse twice quickly , 1 for 15 minutes and 2 
for 5 minutes each. 
3. Incubate with primary antibody (dilute in TTBS) at room temperature for 1 
hour with shaking. 
4. Wash like in step B. 
5. Incubate with secondary antibody (dilute in TTBS) at room temperature 
with shaking. 
6. Wash as in step B plus add 2 additional 5 minute washes. 
G. Detection 
1. Mix an equal volume of detection solution 1 with detection solution 2 
to give sufficient volume to cover membranes. 
2. Drain the excess buffer from washed membrane(s) and place them on 
a piece of SaranWrap, protein side up. Add the detection reagent to the 
protein side of the membrane, so that the reagents are held by surface 
tension on the surface of the membrane. Do not allow the surface of the 
membranes to become uncovered. 
3. Incubate for precisely 1 minute at room temperature. 
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4. Drain off excess detection reagent and wrap membranes in 
SaranWrap. Gently smooth out air pockets. 
5. Place the membranes, protein side up, in film cassette. 
6. Add film, wait 15 seconds, develop film. Add more film if necessary. 
H. Amido Black staining of the nitrocellulose membrane 
1. Incubate membrane for 1 to 2 minutes in stain solution 
2. Destain with amido black destain solution. Change if necessary. 
3. Rinse membrane(s) in TBS or deionized HjO before drying. 
I. Buffers 
10% Acrylamide Separating Gel 
9.9 ml H2O 
8.3 ml 30% Acrylamide (29:1) 
6.3 ml 1.5MTris(pH8.8) 
250 Ml 10%SDS 
250 pi 10% Ammonium Persulfate (APS) 60 Ml 10% APS 
5% Acrylamide Separating Gel 
4.1 ml H2O 
1.0 ml 30% Acrylamide (29:1) 
750 Ml 1.0MTris(pH6.8) 
60 Ml 10%SDS 
Running Buffer 
25 mM Tris(pH8.3) 
250 mM Glycine 
0.1% SDS 
Transfer Buffer 
25 mM Tris 
192 mM glycine 
20% methanol 
2X Sample Buffer 
100 mM Tris (pH 6.8) 
220 mM DTT 
4% SDS 
0.2% Bromophenol Blue 
20% Glycerol 
Coomassie Blue Stain 
0.25 g Coomassie Brilliant Blue R250 
90 mL Methanol: HjO (1:1) 
10 mL Glacial Acetic Acid 
Filter, Whatman 1 
Coomassie Destain Solution Amido Black Destain Solution 
90 ml Methanol: H2O (1:1) 25% Isopropanol 
10 ml Glacial Acetic Acid 10% Acetic Acid 
Amido Black Stain 
0.1% Amido Black 
25% Isopropanol 
10% Acetic Acid 
TBS (pH 7.5) 
20 mM Tris 
500 mM NaCI 
Blocking Solution 
5% non-fat dry milk + TTBS 
TTBS 
Add 500 Ml Tween-20 to 1L TBS 
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APPENDIX D. EXAMINATION OF THE LAMBDA IMMUNOGLBULIN 
LIGHT CHAIN PROMOTER AND THE OCTAMER MOTIF 
INTRODUCTION 
The objective of this research was two-fold. First, It was done to determine if the 
lambda light chain immunoglobulin promoter is active in B cell (DT40) and/or T cells (MSB1). 
Next, the octamer motif was mutated to determine if it was necessary for gene expression in 
either of the cell types mentioned above. 
MATERIALS 
DT40 (B cell line), MSB1 (T cell line), & Chicken Lambda Light Chain Immunoglobulin 
Gene, Dr. C.B. Thompson, University of Chicago. 
pSV-S-Galactosidase Vector, Promega, Madison, Wl Cat. #: El 081. 
B-Galactosidase Enzyme Assay System with Reporter Lysis Buffer, Promega, Madison, 
Wl Cat.#: E2000. 
pCAT Reporter Vectors, Promega, Madison, Wl Cat. #: E1041, 1021, & 1031. 
a-Chicken CD4 & CDS, Southern Biotechnology, Birmingham, AL, Cat.#: 8210-02 & 
8220-02. 
PGEM-T Vector Systems, Promega, Cat. #: A3600. 
METHODS 
Cell Lines (MSB-1 and DT-40) 
A. DT-40 Medium 
DMEM 500 mis 
Tryptose Phosphate 30 mis 
Newbom Calf Serum (Heat-inactivated) 60 mis 
Chicken Semm (Heat-Inactivated) 24 mis 
1 M HEPES pH 7.3 6 mis 
Nystatin (1:10 dilution) 0.5 mis 
Penicillin-Streptomycin 5 mis 
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B. MSB-1 Medium 
DMEM 
Tryptose Phosphate 
Newborn Calf Serum (Heat-inactivated) 
Chicken Serum (Heat-Inactivated) 
1 M HEPES pH 7.3 
Nystatin (1:10 dilution) 
Penicillin-Streptomycin 
500 mis 
30 mis 
60 mis 
24 mis 
6 mis 
0.5 mis 
5 mis 
C. Growth Conditions (7% COj, 37°C) 
D. Thawing Cells 
1. Remove cells from Nj and quick thaw in ST'C waterbath with gentle 
agitation 
2. As soon as cells are thawed, add cell suspension to 5 ml of 4°C culture 
media in sterile tube 
3. Spin at 1,200 rpm for 5 minutes at 4''C 
4. Remove supernatant and resuspend in 5 ml fresh culture media. Incubate 
in 25 cm^ tissue culture flasks standing upright 
5. Check cell viability the next day and adjust cell density to 5 x 10® / ml. 
Incubate with flasks in horizontal position. 
E. Freezing Cells 
1. Count cells and pellet enough cells to have 1x10^ per vial. 
2. Resuspend cells in culture media at a density of 0.5 mis per 1x10^ cells. 
3. Add freezing media at 1:1 to the cell suspension slowly and mixing well. 
4. Aliquot to labeled freezing viles at 1 ml (1x10^ cells) per vial. 
5. Freezing Media 
3.3 ml culture media 
1.5 ml Newborn serum 
1.2 ml DMSG 
Filter sterilize. 
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Flow Cytometry 
A. Protocol - Indirect 
1. Centrifuge cells (changes depending on source) 
2. Wash cells with PBA 
3. Centrifuge at 400xg for 5 minutes at 4°C 
4. Add 5 mis of PBA and repeat step 2 
5. Adjust cell concentration to approx. 2x10^ cells / ml (Do not go too low on 
concentration, if anything, go a little higher) 
6. Add 50 [Jl of the cells to a tube and 50 |jl of a 1:50 dilution of primary 
antibody (Use a 12 x 75 mm siliconized glass tube) 
7. Incubate tube on ice for 30 minutes 
8. Add 2 ml of PBA and repeat step 2 
9. Repeat step h 
10. Add 50 |jl of a 1:50 dilution of the secondary antibody (FITC-conjugated) 
11. Incubate on ice for 30 minutes shielded from light 
12. Add 2 ml of PBA and repeat step c 
13. Repeat step I 
14. Resuspend pellet in 500 pl of 1% paraformaldehyde (made fresh) 
15. Cap and store tubes in the refrigerator (May want to put in box to shield 
from light) 
B. Controls 
1. Blank (Autofluorescense); Add PBA rather than antibody at both places 
Secondary; Add PBA rather than the primary antibody 
2. Isotype: Add isotype primary antibody in place of normal antibody (i.e. 
Mouse IgG isotype rather than Mouse anti-chicken CD4) 
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C. Dilutions 
1. CD4 and CDS: 1 to 50 dilutions 
2. Isotype: 1 to 100 dilution 
3. Goat anti-mouse-FITC-conjugated: 1 to 25 (Southern Biotechnology) 
-Dilute stock of old Goat anti-mouse-FITC-conjugated(reconstituted) 1 
to 5 and than use same as antibody from Southern Biotechnology 
p. Solutions 
2XPBS PBA 
lOOmMNaCI 1.1XPBS 
4.5 mM KCI 2% Bovine Serum Albumin 
7 mM Na2HP04 0.1% Sodium Azide 
3 mM KH2PO4 
1 % Paraformaldehyde 
1. Into a clean 50 ml tube, weigh 300 mg of paraformaldehyde 
2. Heat waterbath to 60°C 
3. Add 15 ml of water to tube, mix 
4. Add 100 Ml 1M NaOH, mix 
5. Place tube in waterbath, mix occasionally until all solids dissolve 
6. Add 100 Ml 1M HCI 
7. Add 15 mi 2X PBS 
8. Label and date tube 
Subcloning promoter 
A. Full length promoter 
1. Use PGR to amplify full length chicken lambda light chain promoter (466 bp) 
Template; 10 ng plasmid containing full length chicken lambda immunoglobulin 
gene 
IgPFor 5' GCA GGT GGT TCA AAG AAA CGT 3' 
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IgPRev 5' GGC GGA ATC CCA GCA GCT GTG T 3" 
PGR Program: 
1. 94° C for 4' 
2. 94° C fori' 
3. 58° C for 45" 
4. 72° C for 30" 
5. GOTO step 2 and repeat 29 times 
6. 72° C for 10" 
2. Subclone PCR product into pGEM-T (Promega) PCR cloning kit 
3. Remove insert from pGEM-T vector {Sph\ and Sail) and subclone into pCAT-
Basic vector (Promega) 
4. Remove insert from pCAT-Basic (HindWl and Sail) and subclone into pCAT-
Enhancer vector (Promega) 
B. Site-directed mutagenesis (Ho etai, 1989) 
1. PCR technique to amplify fragment with mutated sites. Designed primers to 
mutate the octamer site. One primer (IgPMutI) was used with the fonward primer to 
amplify a fragment of 374 bp while the other primer (lgPMut2) was used with the 
reverse primer and amplified a 111 bp fragment. PCR program and template same 
as above (A. Full length promoter). 
IgPMutI 5'CCCCCTATGAATATAACTCC3' 
lgPMut2 5'GGC GGA ATC CCA GCA GCT GT 3' 
Mutated octamer ATaTtCAT 
2. Reamplify mixed fragments with full length primers described above. 
3. Subclone as described above (A. Full length promoter). 
Reporter Assay 
A. Electroporation 
1. Wash cells twice with PBS 
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2. Resuspend cells to a concentration of -1x10^ cells per 500 [il of PBS. 
3. To 5 mm gap cuvette add 
20 |jg of plasmid DNA 
100 ng of sheared salmon sperm 
-1x10' cells/500 Ml PBS 
4. Incubate on ice for 10 minutes. 
5. Charge Electroporator for 3 minutes with following settings 
DT-40 / MSB-1 
300-V 
500 pF 
6. Incubate cuvette on ice for 10 minutes following charge. 
7. Transfer sample to 60 mm plate with 9 ml of appropriate tissue culture 
medium. 
8. Incubate plates for 24 to 48 hours. 
B. Ceil Lystate 
1. Collect cells by centrifugation. 
2. Wash cells twice with PBS. 
3. Wash cells once in TEN (40 mM Tris-HCI, pH 7.5; 1 mM EDTA, pH 8.0: 
150 mM NaCI). 
4. Incubate tube(s) in dry ice / methanol bath until frozen. 
5. Incubate tube(s) at 37° C until sample thaws 
6. Vortex mix. 
7. Repeat d to f two more times 
8. Spin for 5 minutes in microcentrifuge. 
9. Transfer supernatant to fresh tube. 
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(i-Galactosidase Assay (Promega - Microtiter Plate Assay) 
1. Prepare standards for standard curve as follows 
Milliunits 
Vol. of 
1:10,000 Stock 
Vol. of 1X Reporter 
Lysis Buffer 
0.0 
1.0 
2.0 
3.0 
4.0 
5.0 
OmI 
IOMI 
20|jl 
30MI 
40KII 
50mI 
50|JI 
40|jl 
SOmI 
20|JI 
10^1 
OMI 
2. Add 20 to 50 pi of cell lysate to a well in 96 well plate (Flat bottom, 
untreated). 
3. Fill sample volume to 50 pi with 1X reporter lysis buffer. 
4. Add 50 |jl of 2X Assay Buffer to each well. 
5. Mix plate, cover and incubate at 37° C for 30 minutes (Maximum of 3 
hours). 
6. Read the absorbance of the samples at 420 nm. 
D. CAT Assay 
1. Prepare reaction mixture (n+1). 
9.8 pi 2.5 mg/ml Butyryl-CoA 
0.2 pi ^^C-labelled choioramphenicol 
2. Aliquot supematants from the cell lysates into microcentrifuge tubes. 
3. Heat cell iysates at 68° C for 5 minutes. 
4. Cool lysates on ice. 
5. Dilute samples with Tris-HCI H 8.0 to a final conc. of 100 mM in 100 pi 
(i.e. 40 pi of sample; 50 pi ddi-ijO) Make sure samples are resuspended 
0.25 M Tris. 
6. Preincubate reaction mixture at 37° C for 2 minutes. 
7. Prepare standard curve. 
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a. Use 1000 U/ml (1 U/pl) CAT enzyme as the stock enzyme solution in 100 
mM Tris pH 8.0. 
b. Make all dilutions of the enzymes in 100 mM Tris pH 8.0. Aliquot diluted 
CAT. Keep on ice. 
c. Add 10 pi CAT stock to 990 pi 0.1 M Tris pH 8.0. Serial dilution (1:10) of the 
1:100. 
8. Start reaction by adding 10 pi reaction mix per sample (Only do a maximum of 
ten samples at time to keep reaction linear). 
9. Incubate control for 30 minutes to 1 hour at 37° C, incubate sample for 4 hours. 
10. Stop reaction by adding 200 pi TMPD:Xylene (2:1). 
>11. Vortex tubes for 30 s and spin for 2 minutes in microcentrifuge. 
12. Carefully remove 125 pi of upper organic phase into scintillation vial. 
13. Add 5 ml of Scintiverse BD scintillation cocktail and count. 
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Table 1. Initial CAT assay results with different concentrations of protein being used in 
assay. 
DT40 Assay 1 Assay 2 Assay 3 Assay 4 
Amt of Protein 16 Mg 50 |jg 24 MQ 32 Mg 
Nothing 36 31 -106 30 
RSV-B-gal 31 47 33 33 
pOPRS-VI CAT 38 31 35 57 
pCAT-E 567 6547 3934 4760 
pCAT-B+lgP 32 51 38 54 
pCAT-B+MlgP 27 38 32 37 
pCAT-E+lgP 585 722 831 1101 
pCAT-E+MlgP 41 51 48 67 
MSB1 Assay 1 Assay 2 Assay 3 Assay 4 
Amt of Protein 40 |jg 50 fjg 32 pg 32 Mg 
Nothing 28 32 28 48 
RSV-S-gal 29 44 33 37 
pOPRS-VI CAT 34 41 27 35 
pCAT-E 2930 5576 3165 3050 
pCAT-B+lgP 32 96 74 86 
pCAT-B+MlgP 29 40 26 31 
pCAT-E+lgP 39 131 75 43 
pCAT-E+MlgP 41 46 36 36 
Table 2. Repeat of Table 1 cell lysate/CAT assay using 20 pg of total protein for each 
assay. 
DT40 Assay 1 Assay 2 Assay 3 Assay 4 Mean STD Dev SEM 
Nothing 36 30 50 36 38.0 8.5 2.1 
pCAT-B+lgP 48 21 52 53 43.5 15.2 3.8 
pCAT-B+MlgP 52 41 45 40 44.5 5.4 1.4 
pCAT-E+lgP 817 270 873 706 666.5 273.3 68.3 
pCAT-E+MlgP 66 63 51 63 60.8 6.7 1.7 
MSB1 Assay 1 Assay 2 Assay 3 Assay 4 Mean STD Dev SEM 
Nothing 31 35 36 34 34.0 2.2 0.5 
pCAT-B+lgP 38 50 70 69 56.8 15.5 3.9 
pCAT-B+MlgP 37 28 32 33 32.5 3.7 0.9 
pCAT-E+lgP 44 73 72 44 58.3 16.5 4.1 
pCAT-E+MlgP 30 38 35 38 35.3 3.8 0.9 
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Figure 1. Comparison of RSV, CMV and SV40 promoters in two chicken lymphoid 
cell lines. pOPRS-VI-CAT, RSV promoter; pCMV-CAT, CMV promoter: pCAT-
Control, SV40 promoter and enhancer. 
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